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Metabolic syndrome (MetS) is major public health concern. Diet can play a major role in 
the prevention and/or progression of the MetS. At 8 weeks of age, male obese Zucker rat (OZR) 
and their lean littermates (LZR) were placed on a control or an 8% w/w whole red raspberry 
(WRR)-enriched diet for 8 weeks. Circulating levels of inflammatory cytokines and their gene 
expression in the liver and adipose tissue were evaluated. Several lipid markers were measured 
in the plasma, liver and adipose tissue. The expression of eight genes related to lipid metabolism 
were evaluated, both in liver and adipose tissue. Phenylephrine (Phe)-induced vasoconstriction 
and acetylcholine (Ach)-induced vasorelaxation were measured in aortic rings in the presence or 
absence of L-N-monomethyl-arginine (L-NMMA) and mefenamic acid (MFA). Prostanoid levels 
were measured in the aortic effluent. Vascular function related gene were analyzed in the aorta. 
Plasma levels of interleukin-6 (IL-6) decreased in the OZR consuming a WRR diet compared to 
the OZR-C (p<0.05). Hepatic expression of pro-inflammatory markers IL-6, tumor necrosis 
      
factor-alpha (TNF-	𝛼), and nuclear factor kappa-B (NF-𝜅B) was also significantly down-
regulated (p<0.05) with the WRR diet in the OZR. Following consumption of WRR, the 
expression of IL-6 and TNF-𝛼 in the OZR were significantly down-regulated (p<0.05) in the 
adipose tissue. A WRR enriched-diet reduced plasma cholesterol and HDL-C and increased 
plasma TG while it decreased hepatic TG accumulation in the OZR. The OZR assigned to a 
WRR exhibited up-regulation of microsomal triglyceride transfer protein and down-regulation of 
fatty acid synthase expression in the liver. The WRR diet partially restored aortic response in the 
OZR-WRR aorta (p< 0.05) compared to OZR- C. The OZR-WRR group pre-treated with L-
NMMA increased (p< 0.05). Pre-treatment with L-NMMA, maximal relaxation response was 
higher in the OZR compared to the LZR (p< 0.05). With L-NMMA, maximal relaxation 
response in OZR-WRR (p< 0.05) was lower. Prostacyclin I2 concentration was attenuated in the 
OZR-WRR (p< 0.05). Aortic expression of eNOS and COX-2 were downregulated in the OZR-
WRR (p< 0.05). In conclusion, WRR attenuates inflammation, plays a hepatoprotective role and 
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The term Metabolic Syndrome (MetS) was first coined by Haller and Hanefield in 1975. 
The MetS is characterized by a combination of obesity, hypertension, dyslipidemia and elevated 
glucose increasing the risk of cardiovascular disease and type 2 diabetes (O’Neill & O’Driscoll, 
2015). The major contributor of the MetS is lifestyle such as physical inactivity and excess 
dietary intake of fats and carbohydrates (O’Neill & O’Driscoll, 2015). There is a high prevelance 
of the MetS globally and it is expected to increase (O’Neill & O’Driscoll, 2015). According to 
the United States 2000 census it is estimated that about 47 million of the U.S. population had the 
MetS (O’Neill & O’Driscoll, 2015).  
One condition associated with the MetS is inflammation. Inflammation is a defense 
response that is facilitated with persistent metabolic disturbances (Mittal, Siddiqui, Tran, Reddy, 
& Malik, 2014). Obesity-induced inflammation is associated with insulin resistance, 
hyperglycemia, dyslipidemia and hypertension (Castro, Macedo-de la Concha, & Pantoja-
Meléndez, 2016). This inflammatory state increases the production of pro-inflammatory 
adipokines, chemokines, cytokines by adipocytes and oxidative stress (Castro et al., 2016). 
Unresolved inflammatory condition results into systemic inflammation causing further metabolic 
damages (Castro et al., 2016).  
Dyslipidemia associated with the MetS, consists of three components: fasting and post-
prandial triglycerides, decreased high-density lipoprotein and increased small, dense low-density 
lipoprotein particles (Ruotolo & Howard, 2002). Abnormal lipid ratios increases an individual’s 
risk of atherosclerotic lesions and fatty liver disease (S. Grundy, 1997).  
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Patients with the MetS or contributing elements to it, commonly have altered vascular 
function, such as an abnormal vascular tone from a physiological contribution such as reactive 
hyperemia, elevated metabolic demand or pharmacological contribution such as infusion of 
endothelium-dependent agonist (e.g. acetylcholine, methacholine, and insulin) (Frisbee & Delp, 
2006). Vascular dysfunction is accompanied by a greater risk of cardiovascular events.   
Over the past several years pharmacotherapies have been used to reduce the risks of 
MetS. Current therapies have side effects which have been identified as the major reason patients 
discontinue therapy, increasing risks associated with the MetS (Ahuja & Chou, 2016). An 
alternative to the use of pharmacotherapies is a diet rich in plant foods as a preventative and/or 
reversible approach for many conditions associated with the MetS (Pandey & Rizvi, 2009). 
There is a growing interest in nutraceutical agent interventions due to their various medicinal 
properties with little to no side effects (Probst, Guan, & Kent, 2017).  
In particular, red raspberries (Rubus idaeus) are unique compared to other berries due to 
their distinct phenolic profile and are good dietary sources of antioxidants (Cevik, Turker, & 
Kizilkaya, 2013). Their main components are ellagitannins and anthocyanins as well as vitamin 
C, manganese, fiber and other nutrients (Venketeshwer Rao & Snyder, 2010). Whole red 
raspberries and their extracts have been shown to have various potential health-promoting 
benefits including attenuating inflammation, altering lipid metabolism and restoring vascular-
related abnormalities (Burton-Freeman, Sandhu, & Edirisinghe, 2016) (Teng et al., 2017). 
However, scarce research investigates the benefits of whole red raspberries (WRR) related to 
inflammation, dyslipidemia and vascular dysfunction in a valid in vivo model of the MetS.  
The obese Zucker rat (OZR) is an ideal model for the MetS due to its similar 
multifactorial conditions to that of human diagnosed with MetS. The OZR has a mutation in the 
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leptin receptor gene (Lepr) (fa/fa). This mutation causes early-onset morbid obesity, 
hyperphagia, reduced energy expenditure, alteration of glucose homeostasis, dyslipidemia, and 
inflammation (Clément et al., 1998). At 8 weeks all the abnormalities associated with MetS are 
present in the OZR (Aleixandre de Artiñano & Miguel Castro, 2009). Thus, in this study we 
examined the role of WRR as a potential candidate to improve conditions associated with the 
MetS, in the OZR, a genetic model of the MetS.  
Thus, the focus of this study is to explore the possible relationship between WRR 
consumption and conditions of the MetS, in particular inflammation, dyslipidemia and 
endothelial dysfunction in the obese Zucker rat, a model of the MetS.  
The goal of this research was to examine the role of WRR as a potential candidate to 
attenuate inflammation, normalize lipid metabolism, and improve endothelial dysfunction 
associated with MetS, in the OZR. The objectives were to determine whether WRR have the 
potential to: 
1. Attenuate inflammation by measuring concentrations and gene expression of pro-and 
anti-inflammatory markers in the plasma, liver and abdominal adipose tissue;  
 
2. Improve blood lipid levels, gene expression involved in lipid metabolism in the liver 
and abdominal adipose tissue and hepatic structure and; 
 
3. Improve endothelial dysfunction associated with MetS, by studying its aortic 
response to vasoconstriction, vasodilation, determine the metabolic pathways red 
raspberries modulate related to vascular tone and aortic gene expression associated 
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CHAPTER 2 
2. LITERATURE REVIEW 
2.1 Metabolic Syndrome   
Metabolic syndrome (MetS) started as a concept rather than a diagnosis (Kaur, 2014). 
Since the 1920’s, literature demonstrates the association between obesity, atherogenic 
dyslipidemia, elevated blood pressure, elevated glucose and a pro-thrombotic and pro-
inflammatory state (Table 1). Moreover, MetS increases an individual susceptibility to additional 
conditions such as fatty liver, sleep disturbances, cholesterol gallstones, polycystic ovary 
syndrome, asthma and cancer (S. M. Grundy, Brewer, Cleeman, Smith, & Lenfant, 2004). For an 
individual to be diagnose with MetS, they must present at least three of the above risk factors. 
MetS has been come to known as the constellation of interconnected physiological, metabolic, 
biochemical and clinical abnormalities that is directly linked to cardiovascular disease (CVD) 
and type 2-diabetes mellitus (T2D) (Kaur, 2014) (Figure 1). MetS is a major public health 
problem and is escalating quickly, both in developed and underdeveloped countries. MetS does 
not only affect the individual, but also increase risks for their offspring. Over 50% of women 
who enter pregnancy are classified as obese, resulting in short and long-term child abnormalities 
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Table 1: Criteria for clinical diagnosis of the Metabolic Syndrome.a 
Measure Reference Range 
Elevated Waist Circumference Male:	≥40 in. (≥102cm) Female: ≥35 in. (≥88cm) 
Elevated Triglycerides ≥150 mg/dL 
Reduced HDL-C Male: <40 mg/dL Female: <50 mg/dL 
Elevated Blood Pressure Systolic: ≥130 mmHg Diastolic: ≥85 mm/Hg 
Elevated Fasting Glucose ≥100 mg/dL 
Key: 
HDL-C: High-Density Lipoprotein Cholesterol 
mg/dL: Milligrams per Deciliter  
mmHg: Millimeter of Mercury 
 
a Diagnosis based on the of three of five factors (S. M. Grundy, 2016) 
 
Obesity is excess body fat and is typically measured using body mass index or weight 
circumference (O’Neill & O’Driscoll, 2015). The American Heart Association reported that 154-
157 million adults in the United States are overweight or obese (O’Neill & O’Driscoll, 2015). 
Subcutaneous-abdominal obesity is metabolically more damaging due to the increase size, 
number of fat deposits and dysfunction adipocytes within the abdominal cavity which surrounds 
the major organs creating a greater risk for MetS (Nugent, 2004). Excess adipose contributes and 
influences of mediators including pro-inflammatory factors such as interleukin- 6 (IL-6), tumor 
necrosis factor-alpha (TNF-𝛼), resistin, leptin, angiotensinogen, and plasminogen activator 
inhibitor -1 (S. M. Grundy, 2016). Additionally, dysfunctional adipocytes associated with obesity 
induces oxidative stress (Soares & Costa, 2009). Chronic imbalance of adipocyte function result 
in several risk factors such as: insulin resistance, hyperglycemia, elevated lipid profile (increase 
cholesterol, triglycerides and small, dense-LDL particles, decrease HDL-particles), hypertension, 
and atherosclerosis (Soares & Costa, 2009). 
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Obesity-induced inflammation have an unfavorable effect on lipid metabolism. 
Dyslipidemia is characterized as an abnormal amount of lipids, increased fatty acids, elevated 
triglycerides, decreased high-density lipoprotein (HDL)-cholesterol, and heightened levels of 
small, dense low-density lipoprotein (LDL) (O’Neill & O’Driscoll, 2015). Lipid abnormalities 
are associated with increased risk of cardiovascular events and fatty liver disease (Tóth, Potter, & 
Ming, 2012). According to the Nation Health and Nutrition Examination Survey, the prevalence 
of dyslipidemia is approximately 21% of adults in the United States (Tóth et al., 2012).    
The combination of obesity-induced inflammation and dyslipidemia negatively 
influences the function of blood vessels resulting in vascular dysfunction. Vascular dysfunction 
contributes to atherosclerotic plaques leading to severe cardiovascular complications such as 
hypertension, stroke, ischemic heart disease, myocardial infarction or coronary syndromes 
(Figure 1) (Sitia et al., 2010). Each year approximately 1.5 million U.S. adults suffer from a heart 
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Figure 1: Overview of the Metabolic Syndrome (MetS). 
 
Key: NF-𝜅B (Nuclear Factor Kappa); TNF-𝛼 (Tumor Necrosis Factor-Alpha); IL-6 
(Interleukin-6); CRP (C-Reactive Protein); VLDL (Very Low-Density Lipoprotein); TG 
(Triglycerides); NO (Nitric Oxide); eNOS (Endothelial Nitric Oxide Synthase); TXA2 
(Thromboxane A2); PGI2 (Prostacyclin I2). 
 
Figure modified from (Eckel, Alberti, Grundy, & Zimmet, 2010) 
 
2.2 Metabolic Syndrome and Inflammation 
Inflammation is a major hallmark in obesity, atherosclerosis, dyslipidemia, T2D, and 
hypertension (Ouchi, Kihara, Funahashi, Matsuzawa, & Walsh, 2003). In most cases the 
underlining cause of the MetS is obesity (Gade, Schmit, Collins, & Gade, 2010). Obesity is 
associated with other medical conditions such as several forms of cancer (J. Park, Morley, Kim, 
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Clegg, & Scherer, 2014), renal and liver diseases (Praga & Morales, 2017)(Marchesini, 
Moscatiello, Di Domizio, & Forlani, 2008), polycystic ovarian syndrome (Barber, McCarthy, 
Wass, & Franks, 2006), sleep apnea (Marien & Rodenstein, 2008), and chronic inflammation 
(Esser et al., 2014). The inflammatory response releases inflammatory mediators including 
chemokines, cytokines, vasoactive amines, and eicosanoids (Qatanani & A.Lazar, 2007). 
Increased pro-inflammatory markers, such as C-reactive protein (CRP), tumor necrosis factor 
(TNF)-alpha, interleukin-6 (IL-6), nuclear factor kappa-light-chain-enhancer of activated B cells 
(NF-𝜅B) and decreased anti-inflammatory markers such as adiponectin correlate with increased 
risks associated with MetS (Esser et al., 2014). Additionally, production of reactive oxygen 
species (ROS) is central to the progression of the inflammatory state (Belemets et al., 2017). 
These ROS act as a signaling molecule and a mediatory of inflammation (Belemets et al., 2017). 
ROS that contribute to prolonged inflammation include superoxide anion, hydroxyl radical 
hydrogen peroxide and hypochlorous acid (Belemets et al., 2017).    
There are three major sites that are implicated by inflammation: the liver, intestine and 
adipose depots (Mendrick et al., 2018). The release of inflammatory factors at one of these sites 
promotes an inflammation in neighboring tissues, thereby amplifying the inflammatory response 
and tissue dysfunction/damage (Mendrick et al., 2018). At sites of inflammation cytokines are 
recruited and macrophages differentiate (Baker, Hayden, & Ghosh, 2011). Two types of 
macrophages M1 and M2 are responsible for the inflammatory response based on function and 
cytokine expression (Figure 2) (Baker et al., 2011). The M1 macrophages produces pro-
inflammatory cytokines such as IL-1, IL-6 and TNF-𝛼 (Baker et al., 2011). These M1 
macrophages are responsible for chronic inflammation in metabolic diseases (Baker et al., 2011). 
For example, accumulation of M1 macrophages in the adipose tissue in the obese state of mice 
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and humans (Cinti et al., 2005). The second type of macrophage, M2, is responsible for wound 
healing responses, and secretes anti-inflammatory cytokines such as IL-4 and IL-10 (Baker et al., 
2011). It has been previously reported that lower IL-10 levels are associated with obesity 
(Manigrasso et al., 2005), insulin sensitivity (Han, Patterson, Speck, Ehses, & Levings, 2014) 
and T2D (Mittal et al., 2014).  
 
Figure 2: Pro-inflammatory response to stimuli. 
 
Key: NF-𝜅B (Nuclear Factor Kappa); TNF-𝛼 (Tumor Necrosis Factor-Alpha); IL-6 
(Interleukin-6); CRP (C-Reactive Protein) 
 
Figure modified from (Jung & Choi, 2014) 
 
 
      10 
Nuclear Factor-𝜅B -The central regulatory of the immune system and inflammation is the 
transcription factor, nuclear factor κB (NF-	κB) (Baker et al., 2011). There are five structurally 
related members of NF-	κB: NF-	κB1 (p50), NF-	κB1 (p52), RelA (p65), RelB, and c-Rel (Liu, 
Zhang, Joo, & Sun, 2017). The NF-	κB protein is normally sequestered in the cytoplasm with a 
family of inhibitory proteins, I-Kappa B Kinase and activated by one of two major pathways, the 
canonical that leads to p50/RelA and P50/c-Rel dimers and noncanonical that leads to p52/RelB 
dimer (Liu et al., 2017)(M. Park & Hong, 2016). The canonical pathway responds to cytokine 
receptors, pattern-recognition receptors, tumor necrosis factor (TNF) receptors, T-cell and B-cell 
receptors (Liu et al., 2017). Expression of inflammatory cytokines, such as IL-1, IL-6, IL-12, 
TNF-𝛼, cyclooxygenase-2 chemokines and additional inflammatory mediators are mediated by 
the recruitment of either M1 or M2 macrophages by NF-	κB (Baker et al., 2011). This pathway 
activates an auto feedback loop, which results in increased levels of NF-	κB activity (M. Park & 
Hong, 2016). The NF-	κB signaling pathway plays a key role in a number of inflammatory 
diseases such as rheumatoid arthritis, inflammatory bowel disease, multiple sclerosis and MetS 
(M. Park & Hong, 2016). Thus, suppressing NF-	κB activation is the focus of combating chronic 
inflammatory diseases.  
 
Tumor Necrosis Factor-Alpha - Tumor necrosis factor – alpha (TNF-𝛼) is typically not 
detectable in healthy individuals (Bradley, 2008). However, elevated levels of TNF-𝛼 are found 
in acute and chronic inflammatory conditions including trauma, rheumatoid arthritis, and MetS 
(Bradley, 2008). NF-	κB activity regulates TNF-𝛼 transduction, also referred to as the TNF-NF-
	κB pathway (Bradley, 2008). The expression of TNF-𝛼 is triggered by binding to one of two 
receptors TNFR1 and TNFR2 (Popa, Netea, van Riel, van der Meer, & Stalenhoef, 2007). The 
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expression of TNF receptors are regulated by a number of stimuli including TNF, IL-1, IL-10 
(Bradley, 2008). The signaling cascade leads to cell death, survival, differentiation, proliferation, 
and migration  (Bradley, 2008). Circulating TNF-𝛼 is a major contributor in lipid modifications 
resulting in the development of atherosclerotic plague through increase in leukocyte adhesion, 
transendothelial migration, and lipid modifications (Bradley, 2008)(Popa et al., 2007). 
Additionally, pro-inflammatory cytokine TNF-𝛼 contributes to impaired insulin sensitivity and 
increase production of leptin (Popa et al., 2007).   
 
Interleukin-6- The cytokine IL-6 is elevated in an inflammatory state (Scheller, Chalaris, 
Schmidt-Arras, & Rose-John, 2011). IL-6 binds to its complex receptor consisting of the IL-6 
binding type 1 transmembrane glycoprotein (IL-6R) and type 1 transmembrane signal transducer 
protein gp130 (CD130) (Scheller et al., 2011). Binding of IL-6 to its receptors leads to cell 
division, cell death, tumor formation, proliferation and migration (Scheller et al., 2011).  IL-6 is 
responsible for the transition from acute to chronic inflammation by monocyte recruitment, 
angioproliferation and anti-apoptotic functions on T-cells (Gabay, 2006). Elevated IL-6 are 
elevated in several diseases including rheumatoid arthritis, Crohn’s disease, and the MetS 
(Tanaka, Narazaki, & Kishimoto, 2014).  
 
C- Reactive Protein- Elevated levels of CRP are expressed during several inflammatory diseases 
such as rheumatoid arthritis, Crohn’s disease, and the MetS (Sproston & Ashworth, 2018). 
Human CRP has high affinity to phosphocholine residues, but it can also bind to autologous 
ligands include native and modified plasma lipoproteins, damaged cell membranes, 
phospholipids, and apoptotic cells (Pepys, Hirschfield, Pepys, & Hirschfield, 2003). Plasma CRP 
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is synthesized in the liver by hepatocytes (Sproston & Ashworth, 2018). The main inducer of the 
acute-phase response of CRP is IL-6 and to a lesser extent IL-1 and TNF-𝛼 , however, it is not 
sufficient to achieve this alone (Sproston & Ashworth, 2018).  
 
Adiponectin- Adiponectin is an adipocyte-derived anti-inflammatory molecule that is abundantly 
present in human plasma (López-Jaramillo et al., 2014). Levels of adiponectin are negatively 
regulated by the accumulation of adipose tissue and positively associated with insulin sensitivity 
(López-Jaramillo et al., 2014)(Achari & Jain, 2017). The anti-inflammatory effect of adiponectin 
is activated when it binds to one of three receptors (AdipoR1, AdipoR2, and T-cadherin) (López-
Jaramillo et al., 2014).  Binding to receptors AdipoR1, abundant in skeletal muscle and 
AdipoR2, abundant in the liver result in increased hepatic and skeletal muscle fatty acid 
oxidation, increased skeletal muscle lactate production, reduced haptic gluconeogenesis, 
increased cellular glucose uptake, and inhibition of inflammation and oxidative stress (López-
Jaramillo et al., 2014). Binding to T-cadherin in vascular endothelial cells inhibits oxidative 
stress-induced apoptosis (López-Jaramillo et al., 2014).  
 
2.3 Metabolic Syndrome and Lipid Metabolism  
The MetS is associated with atherogenic lipid profile consisting of reduced HDL-C, 
increased plasma triglyceride, apolipoprotein B, intermediate-density lipoprotein levels, and 
smaller, dense LDL particles (Nugent, 2004). Additionally, the MetS contributes to hepatic 
imbalance from excess lipid droplets due to impaired export of triglycerides in the form of 
VLDL, rise in fatty acid delivery, increase de novo lipogenesis, and decrease in oxidation of fatty 
acids in hepatocytes results in fatty liver (Arvind, Osganian, Cohen, & Corey, 2019). Under 
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normal physiological conditions LDL-C levels are normal or marginally elevated, however, 
individuals with the MetS have raised levels of small, dense LDL particles and oxidized LDL 
concentrations which are associated with increased risk of atherosclerosis (Nugent, 2004).  
The liver plays a major role in lipid metabolism serving as the center for lipoprotein 
uptake, formation, and export into circulation, glucose and fatty acid metabolism (Figure 3) 
(Reddy & Rao, 2006). The uptake, transport and storage of lipids require numerous metabolic 
processes (Klop, Elte, & Cabezas, 2013). Following oral intake of dietary fats, triglycerides are 
lipolyzed in the intestinal lumen into free fatty acids and 2-monoacylglycersols and enter the 
enterocytes through passive diffusion or CD36 transporters (Klop et al., 2013). Dietary 
cholesterol enters the enterocytes through the Niemann-Pick C1 Like 1 Protein (Klop et al., 
2013). Once in the enterocyte, triglycerides are reassembled and cholesterol is transformed into 
cholesterol-esters, both packed together into chylomicrons (Klop et al., 2013). Chylomicrons are 
released into the lymphatic system for circulation (Klop et al., 2013). The liver synthesizes very 
low-density lipoprotein (VLDL) containing the apoB100 protein, when dietary triglycerides and 
free fatty acid reach the liver (Klop et al., 2013). Chylomicrons and VLDL deliver free fatty 
acids to heart, skeletal muscle, and adipose tissue for energy and storage (Klop et al., 2013). 
Several enzymes and proteins regulate these particles, such as lipoprotein lipase (LPL) which is 
stimulated by insulin and serves as a docking station and is the primary enzyme for triglyceride 
lipolysis in circulation (Klop et al., 2013). Eventually, chylomicron and VLDL shrink into 
chylomicron remnants and LDL, respectively both being taken up by the liver via multiple 
pathways (Klop et al., 2013). Alternatively, HDL particles are responsible for the uptake of 
excess free cholesterol from peripheral tissue and turning it back to the liver, this is referred to as 
the reverse cholesterol transport (Klop et al., 2013). During transport free cholesterol is esterified 
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into cholesterol-ester by lecithin-cholesterol acyltransferase within the HDL particle (Klop et al., 
2013). Within circulation HDL particle exchanges cholesterol-esters for triglyceride from 
triglyceride-rich lipoprotein via cholesteryl ester-transfer-protein (Klop et al., 2013).  
 
Figure 3: Major pathways of lipoprotein metabolism. 
 
Key: CM (Chylomicron); HDL (High Density Lipoprotein); LDL (Low-Density 
Lipoprotein); IDL (Intermediate Density Lipoprotein); VLDL (Very Low-Density 
Lipoprotein).  
 
Figure modified from (Helkin et al., 2016) 
 
Triglycerides- Dietary fat, primarily in the form of triglycerides (TGs), are absorbed into the 
small intestine, incorporated into chylomicrons and released into the lymphatic system (Kersten, 
2017).  Lipoprotein lipase breakdowns TGs into fatty acids and are stored or used as fuel by fat 
and muscle cells (Kersten, 2017). Under physiological conditions, all chylomicrons are removed 
by the liver by binding to the LDL receptor, the LDL receptor-related protein, hepatic 
triglyceride lipase, and cell-surface proteoglycans (Miller et al., 2011). However, several factors 
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can reduce the fate of chylomicrons resulting in hypertriglyceridemia (Goldberg, Eckel, & 
McPherson, 2011). Hypertriglyceridemia has been associated with vascular disease such as 
atherosclerosis and increased cardiovascular events (Goldberg et al., 2011).  
 
Total Plasma Cholesterol- Cholesterol in the body is either synthesized de novo within our cells 
or consumed from certain foods (Cerqueira et al., 2016). Cholesterol is a major sterol and plays a 
vital role in the functioning of cells as it is a major component of cell membranes and a precursor 
to several steroid hormones (Cerqueira et al., 2016). Cholesterol concentrations contribute to 
membrane fluidity where higher cholesterol content in cell membranes will be more rigid and 
packed whereas, less cholesterol will be more fluid (Cerqueira et al., 2016). Additionally, 
cholesterol is important for cell membrane endocytosis (Cerqueira et al., 2016). Cholesterol also 
serves as a precursor for bile acid, vitamin D, and steroids including androgens, estrogens, and 
progestogens (Cerqueira et al., 2016). Cholesterol itself cannot be dissolved in the bloodstream, 
therefore it is packaged into lipoproteins with other fats for transport (Cerqueira et al., 2016). 
When the ratio of cholesterol to lipids (other fats) in the lipoprotein is high, it is referred to as 
high-density lipoprotein (HDL), whereas when the ratio of cholesterol to lipids in the lipoprotein 
is small, it is referred to as low-density lipoprotein (LDL) (Cerqueira et al., 2016). High levels of 
cholesterol increases an individual’s risk of atherosclerosis and cardiovascular events when 
concentration of LDL is higher than HDL (Cerqueira et al., 2016).  
 
High-Density Lipoprotein Cholesterol- High-Density Lipoprotein (HDL) is a carrier of  free 
cholesterol from peripheral cells back to the liver referred to as reverse cholesterol transport 
(Lingyan Zhou, Li, Gao, & Wang, 2015). Apolipoprotein (Apo) A1 is the primary structural 
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protein of HDL (Lingyan Zhou et al., 2015). HDL particles are dynamic and can be divided into 
several sub-types based on density and size (Lingyan Zhou et al., 2015). HDL is secreted by the 
liver (~70-80% of total plasma HDL) and small intestines (Lingyan Zhou et al., 2015). When 
HDL reaches the liver, HDL receptors (SR-BI) located on hepatocytes, transport cholesterol 
from the particle into the liver (Lingyan Zhou et al., 2015). The cholesterol is then metabolized 
into bile acid which can be excreted as bile or in the feces (Lingyan Zhou et al., 2015). This 
process explains the anti-atherosclerotic effect of HDL (Lingyan Zhou et al., 2015).   
 
Very/ Low-Density Lipoprotein- Lipid storage pool in the liver, de novo synthesis of fatty acids 
and phospholipids contribute to VLDL synthesis (Ramasamy, 2014). ApoB100 is the main 
protein of VLDL, once in the plasma VLDL is hydrolyzed by LPL that form intermediate (IDL) 
(Ramasamy, 2014). With further catabolism  IDL becomes LDL which binds to LDL receptors 
of cells membranes in the clathrin-coated pits (Ramasamy, 2014). Receptor bound LDL is 
internalized by endocytosis and cholesterol is released into the cell (Ramasamy, 2014). The 
expression of the LDL receptor is regulated by both transcriptional and post-transcriptional 
levels of cholesterol (Ramasamy, 2014). Extensive clinical and epidemiological studies have 
demonstrated that increase levels of LDL is associated with development and progression of 
atherosclerosis and cardiovascular events (Crismaru et al., 2020).  
 
Fatty Acid Synthase- The fatty acid synthase (FAS) enzyme is responsible for de novo synthesis 
of fatty acids used for energy storage, membrane assembly and repair, and secretion in the form 
of lipoprotein triglycerides (Jensen-urstad & Semenkovich, 2012). Hepatic fatty acid synthase is 
regulated by insulin, glucagon, cyclic AMP, fructose, glucose, and dietary fat (Jensen-urstad & 
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Semenkovich, 2012). In a fed state, hepatic FAS synthesizes lipids from stored lipid droplets or 
secreted VLDL. Alternatively, FAS promotes 𝛽-oxidation of fatty acids through PPAR𝛼 
activation under nutrient-deficient conditions (Jensen-urstad & Semenkovich, 2012).  
 
Microsomal Triglyceride Transfer Protein- Microsomal Triglyceride Transfer Protein (MTTP) is 
an intracellular protein that transfers lipids, triglycerides and cholesterol esters between 
phospholipid particles (Hussain, Rava, Walsh, Rana, & Iqbal, 2012). MTTP activity is primarily 
present in epithelial cells, small intestine and the liver (Hussain et al., 2012). MTTP is essential 
for the assembly of triglycerides in nascent ApoB-lipoproteins, ApoB binding, lipid transfer 
activity, and membrane association (Hussain et al., 2008).   
 
ATP Binding Cassette Transporter A1- ATP Binding Cassette Transporter A1 (ABCA1) is a 
ubiquitous membrane protein that plays an important role in the formation of HDL particles, 
HDL metabolism and lipid clearance from foam cells (Lingyan Zhou et al., 2015). ABCA1 
mediates the transport of cholesterol across cellular membranes to lipid-poor HDL particles (Yin, 
Liao, & Tang, 2013). Expression level of ABCA1 in cells is regulated by transcription or post-
transcription levels (Yin et al., 2013).  
 
Low Density Lipoprotein Receptor-Related Protein 1- The clearance of circulating atherogenic 
lipoprotein particles via the liver is regulated by low density lipoprotein receptor-related protein 
1 (LRP1) (Van De Sluis, Wijers, Herz, Opin, & Author, 2017). Hepatic LRP1 binds ApoE rich 
particles such as TG rich chylomicron remnants and VLDL (Van De Sluis et al., 2017). LRP1 is 
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the only member of the LDL receptor gene family that is expressed at high levels in hepatocytes 
thus increasing the transport of ApoE rich lipoproteins (Van De Sluis et al., 2017). 
 
Peroxisome Proliferator-Activated Receptor Alpha- Peroxisome Proliferator-Activated Receptor 
Alpha (PPAR𝛼) is ligand-activated transcription factor important for metabolism and 
inflammation (Kersten & Stienstra, 2017). PPAR𝛼 is expressed at the highest levels in the liver 
followed by brown adipose tissue, kidney, heart, skeletal muscle and small intestines (Green & 
Wahli, 1994). PPAR𝛼 promotes and initiates lipid uptake and catabolism of fatty acids via 𝛽-
oxidation to produce ketone bodies (Jensen-urstad & Semenkovich, 2012).  
 
Peroxisome Proliferator-Activated Receptor Gamma- Peroxisome Proliferator-Activated 
Receptor Gamma (PPAR𝛾) exists in two isoforms PPAR𝛾1 and PPAR𝛾2 (L. Wang et al., 2014). 
PPAR𝛾1 is expressed in adipose tissue, large intestines, hematopoietic cells, kidney, liver, 
muscles, pancreas and small intestine. PPAR𝛾2 is primarily expressed in white and brown tissue 
(L. Wang et al., 2014). Overall, PPAR𝛾 regulates adipocytes differentiation, fatty acid and 
glucose metabolism, insulin sensitivity and inflammation (Vamecq & Latruffe, 1999).  
 
Acyl-CoA Oxidase 1- The expression of Acyl-CoA Oxidase 1(ACOX1) is a rate-limiting enzyme 
that is regulated by peroxisomes (Keller et al., 1993). ACOX1 is the first enzyme of  𝛽-
oxidation, the pathway responsible for lipid catabolism (Nguyen et al., 2008). In peroxisomes, 𝛽-
oxidation is responsible for the metabolism of very long chain fatty acids (Nguyen et al., 2008).  
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Acetyl-CoA acetyltransferase- Acetyl-CoA acetyltransferase (ACAT), also known as 
acetoacetyl-CoA thiolase is an enzyme that transforms cholesterol to cholesteryl esters 
(Chistiakov, Melnichenko, Myasoedova, Grechko, & Orekhov, 2017). The ACAT enzyme can 
be found in the mitochondira (ACAT1) or cytoplasm (ACAT2) (Chistiakov et al., 2017). Acetyl-
CoA is derived from glucose, fatty acid, and amino acid catabolism (Shi & Tu, 2015).  
 
Lipoprotein Lipase- Lipoprotein lipase is an enzyme responsible for the metabolism and 
transport of lipids (H. Wang & Eckel, 2009). LPL produced by many tissues including adipose 
tissue, cardiac and skeletal muscle, islets, and macrophages (H. Wang & Eckel, 2009). The LPL 
enzyme produces chylomicron remnants and intermediate LDL by the hydrolyzing TGs of 
chylomicrons and VLDL particles (H. Wang & Eckel, 2009). Additionally, LPL anchors 
lipoproteins to vessel walls for the uptake of lipoprotein particles, promotes lipid exchange 
between lipoproteins, acts as a ligand lipoprotein receptors for lipoprotein uptake and selectively 
facilitates the uptake of lipoprotein-associated lipids and lipophilic vitamins (H. Wang & Eckel, 
2009). Thus, LPL regulates supply of fatty acids to various tissues for either storage or oxidation 
(H. Wang & Eckel, 2009). 
 
2.4 Endothelial Dysfunction  
The blood vessel is composed of three layers: intimal, medial and adventitia (Y. Zhao, 
Vanhoutte, & Leung, 2015). The intimal layer is made-up of a single layer of endothelial cells 
(Y. Zhao et al., 2015). This endothelial layer regulates blood vessel diameter by releasing 
endothelium-relaxant factor nitric oxide and endothelium-contracting factors proteinoids and 
peptides (Y. Zhao et al., 2015). The medial layer is made-up of vascular smooth muscle cells and 
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mediates constriction and dilation of blood vessels (Y. Zhao et al., 2015). Mechanical and/or 
pharmacological activation initiates the contraction of smooth muscle cells by increasing 
intracellular calcium either by the release of internal stores or influx into the cell via calcium 
channels (Y. Zhao et al., 2015). Intracellular calcium binds to calmodulin and activates myosin 
light chain kinase (MLCK) (Y. Zhao et al., 2015). The activated MLCK phosphorylates the 
myosin light chain and leads to a cross-chain between myosin head and actin filaments, resulting 
in contraction (Y. Zhao et al., 2015). The adventitia layer contains nerve endings, perivascular 
adipose tissue and connective elements (Y. Zhao et al., 2015).  
The vascular endothelium is dynamic and has numerous functions including regulation of 
vascular tone, platelet aggregation, coagulation and fibrinolysis (Nugent, 2004). Thus, 
dysregulation of one or more of these functions can occur in the MetS resulting in endothelial 
dysfunction (Nugent, 2004). Hyperinsulinemia and elevated levels of circulating free fatty acids 
disturb the endothelium by impairing the loss of NO bioavailability in the vessel wall (Nugent, 
2004). Damage to the wall initiates coagulation and inflammation further damaging the 
endothelial wall (Nugent, 2004). Thus, altered vascular tone and endothelial dysfunction 
increases clotting factors: fibrinogen, clotting factors VII and VIII, von Willebrand factor which 
result in a pro-thrombotic state and recruitment of inflammatory factors: IL-1, IL-6, TNF-𝛼 and 
CRP which result in mild chronic inflammation in individuals with the MetS, which can lead to 
hypertension (Nugent, 2004).   
Vascular function is a major component of vascular health and disease. It is regulated by 
two major pathways: nitric oxide synthase (NOS) and cyclooxygenase (COX) (Figure 4) 
(Steinberg & Baron, 2002) (Kristo, Kalea, Schuschke, & Klimis-Zacas, 2013). In healthy blood 
vessels these pathways produce a balance of vasoactive mediators such as nitric oxide (NO), 
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thromboxane A2 (TXA2), and prostacyclin (PGI2) (Suganya, Bhakkiyalakshmi, Sarada, & 
Ramkumar, 2016). Nitric oxide, a product of NOS, is a vasodilator that suppresses vascular 
smooth muscle cell proliferation, blood cell adhesion, and lipid peroxidation (Kleinbongard et 
al., 2003)(Napoli et al., 2006). The COX pathway is responsible for prostanoid formation 
including TXA2 and PGI2. Prostacyclin, is a vasorelaxant agent that acts synergistically with NO 
to inhibit platelet aggregation (Vanhoutte, 2003), whereas TXA2 is an endothelium-dependent 
vasoconstrictor and a potent inducer of platelet aggregation (Paul, Jin, & Kunapuli, 1999). 
Alterations in the production of these endothelially-derived factors leads to vascular dysfunction 
which has been observed in individuals with MetS. Thus, initiating and promoting the 
pathogenesis of early vascular events such as atherosclerotic lesions (Tziomalos, Athyros, 
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Figure 4: Vascular tone through the Nitric Oxide and Cyclooxygenase pathway. 
 
Key: NO (Nitric Oxide); eNOS (Endothelial Nitric Oxide Synthase); sGC (Soluble Guanylyl 
Cyclase); GTP (Guanosine Triphosphate); cGMP (Cyclic GMP); COX1 (Cyclooxygenase 1); 
COX2 (Cyclooxygenase 2); TXA2 (Thromboxane A2); PGI2 (Prostacyclin I2); ATP 
(Adenosine Triphosphate); cAMP (Cyclic AMP).  
 
Figure modified from (Bryan, You, Golding, & Marrelli, 2016). 
 
Nitric Oxide- In 1980, Furchgott & Zawadzki, first descried endothelium-dependent relaxation of 
the blood vessels, later proposed to be nitric oxide (NO) (Furchgott & Zawadski, 1980). Nitric 
oxide is a soluble gas with a short half-life, that is synthesized by L-arginine in endothelial cells 
by the enzyme nitric oxide synthase (NOS) (Cannon III, 1998). Nitric oxide is a regulator of 
blood vessel tone, neurotransmission and modulation of the immune system and inflammation 
(Robbins & Grisham, 2003). There are three isoforms of nitric oxide: neuronal NOS (nNOS), 
cytokine-inducible NOS (iNOS) and endothelial NOS (eNOS) (Robbins & Grisham, 2003). An 
important aspect of the production of NO is the presence of tetrahydrobiopterin (BH4) (Silva, 
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Paula, Paulo, & Bendhack, 2016). The cofactor BH4 plays an important part in the oxidation of 
L-arginine for the production of NO (Silva et al., 2016). Depletion and/or oxidation of BH4 by 
various diseases and environmental factors alters the function of NOS by acting as an oxidase 
rather than generating NO (Silva et al., 2016). The uncoupling of NOS generates superoxidase 
anion (O2-) which reacts with NO to form highly reactive and cytotoxic reactive oxygen species 
(ROS) such as peroxinitrite (ONOO-) (Silva et al., 2016).  
 
Inducible Nitric Oxide Synthase- Under normal physiological conditions the expression of iNOS 
is minimal but is increased during infection, chronic inflammation and in tumors (Y. Zhao et al., 
2015). Activation of iNOS requires interferon regulatory factor 1 and NF-𝜅B (Y. Zhao et al., 
2015). Production of iNOS may contribute to vascular dysfunction by limiting the availability of 
BH4, a critical cofactor for eNOS (Y. Zhao et al., 2015).   
 
Endothelial Nitric Oxide Synthase- The eNOS isoform is responsible for the regulation of 
vascular function, in particular the endothelium-derived relaxing factor (Y. Zhao et al., 2015). 
The main source of NO in the vascular endothelium is via eNOS (Mónica, Bian, & Murad, 
2016). The production of NO from eNOS is initiated by several stimuli such as acetylcholine, 
bradykinin, and histamine (Y. Zhao et al., 2015). Activation of eNOS results in an increase of 
intracellular concentration of calcium (Ca2+), the binding of Ca2+ to Ca2+/calmodulin complex 
which initiates the production of NO (Silva et al., 2016). Alternatively, shear stress generated by 
blood flow across endothelial cells activate eNOS without the direct increase of Ca2+ but rather 
by activating phosphatidylinositol 3-kinase and the subsequent Akt and protein kinase A 
pathway (Silva et al., 2016). Additionally, eNOS regulates suppression of vascular smooth 
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muscle cell proliferation, modulation of leukocyte-endothelial interactions and modulation of 
thrombosis (Huang, 2009).  
 
Cyclooxygenase Pathway- The cyclooxygenase (COX) pathway, releases long-chain 
polyunsaturated fatty acids, mainly arachidonic acid (20:4 n-6) from lipids in the cell membrane 
to produce tissue hormones (prostanoids) (Korbecki, Baranowska-Bosiacka, Gutowska, & 
Chlubek, 2014). Four main prostanoids in vivo include: prostaglandin E2, prostacyclin I2, 
prostaglandin D2, and prostaglandin F2  (Ricciotti & Fitzgerald, 2011). The production of 
prostanoids changes due to the inflammation response. Low/uninflamed tissues produce 
generally low levels of prostanoids, whereas there is an increase in prostanoid production in 
acute inflammation (Ricciotti & Fitzgerald, 2011). The production of prostanoids is dependent 
on two main isoforms of COX are cyclooxygenase-1 (COX-1) and cylooxygenease-2 (COX-2) 
(Korbecki et al., 2014). COX-1 is constitutively expressed within tissues whereas COX-2 is 
induced when inflammation is present (Mitchell & Kirkby, 2019). However, both COX’s 
contribute to autoregulation and homeostatic production of prostanoids, thus both can contribute 
during inflammation (Ricciotti & Fitzgerald, 2011).  
 
Cyclooxygenase-2- Cyclooxygenase-2 (COX-2) expression is induced in 
monocytes/macrophages, vascular endothelial cells and colorectal cancer cells in response to 
inflammatory cytokines, laminar shear stress and growth factors (Patrono, 2016). COX-2 is the 
predominate source of prostaglandin formation in inflammation (Ricciotti & Fitzgerald, 2011). 
COX-2 is regulated by post-transcriptional and enzymatic level such as nitric oxide (Tsatsanis, 
Androulidaki, Venihaki, & Margioris, 2006).  
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Prostacyclin I2- Prostacyclin plays a major role in the cardiovascular system as a potent inhibitor 
of platelet aggregation, leukocyte adhesion, vascular smooth muscle cell proliferation, 
vasodilator, anti-mitogenic and inhibits DNA synthesis (Mitchell & Kirkby, 2019). These actions 
are mediated by the binding of Prostacyclin I2 to a rhodopsin-like seven transmembrane 
spanning G-protein receptor, PGI receptor (IP) (Ricciotti & Fitzgerald, 2011). The IP receptor is 
expressed in kidney, liver, lung, platelets, heart and aorta (Ricciotti & Fitzgerald, 2011). Major 
sources of PGI2 are endothelial cells, vascular smooth muscle cells and endothelial progenitor 
cells (Ricciotti & Fitzgerald, 2011). COX2 is the dominant source of PGI2 (Ricciotti & 
Fitzgerald, 2011). Once generated, PGI2 acts on neighboring vascular smooth muscle cells and is 
quickly converted to 6-keto-PGF1𝛼 (Ricciotti & Fitzgerald, 2011).   
 
Thromboxane A2- Thromboxane A2 is predominately derived from platelet COX1, and binds to 
the TP receptor (Ricciotti & Fitzgerald, 2011). The TP receptor couples with Gq/G12/13 and small 
G-proteins that regulate phospholipase C, Rho and adenylyl cyclase (Ricciotti & Fitzgerald, 
2011). The TP receptor is expressed in platelets, smooth muscle and endothelial cells, lungs, 
kidneys, heart, thymus and spleen (Rucker & Dhamoon, 2019). Activation of the TP receptor 
results in platelet adhesion and aggregation, smooth muscle contraction and proliferation, and 
activation of endothelial inflammatory responses (Ricciotti & Fitzgerald, 2011). Thromboxane 
A2 has a 30-second half-life and is quickly converted to TXB2 (Ricciotti & Fitzgerald, 2011). 
Due to the short half-life, TXA2 acts in an autocrine or paracrine manner to activate adjacent 
platelets to amplify the response and produce more TXA2 (Rucker & Dhamoon, 2019)  
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2.5 Red Raspberries (Rubus idaeus) 
Red raspberry (Rubus idaeus), known as the “golden fruit” is a species of the Rosaceae 
family, originated in Europe, northwest Africa and western Asia (Teng et al., 2017)(Matkowski 
et al., 2014). Today, these cultivated berries are produced in United States Washington, Oregon, 
and California regions (Burton-Freeman et al., 2016). Many ancient references of red raspberry 
did not consider the berry as food, but instead plant parts used in folk medicine (Hummer, 2010). 
Raspberries were used as a medicinal plant by the native people soon after the Ice Age and 
harvested by the ancient Greeks as early as 370 BC (Hummer, 2010).  Traditionally, the flesh has 
been used as anti-inflammatory and antimicrobial remedies, the shoots have been used to treat 
common cold, fever and flu-like infections and the leaves have been used to relieve menstrual 
cramps, diarrhea, chronic skin conditions and conjunctivitis (Matkowski et al., 2014).  
Red raspberry have many cultivars mainly due to selection for good yield and pest 
resistance (Beekwilder, Hall, & De Vos, 2005). Raspberries contain essential minerals, vitamins, 
fatty acids, fiber and a range of phytochemicals that have been shown to have healthful 
properties (Venketeshwer Rao & Snyder, 2010). Red raspberries are low in calories providing 52 
kcal per 100 grams of fresh fruit and high in dietary fiber providing 6.5 grams/ 100 grams of fruit 
(Table 2) (Venketeshwer Rao & Snyder, 2010). The seeds of raspberries contain healthy source 
of essential fats with 97.8% unsaturated fatty acids and low ratio (1.64) of omega-6 to omega-3 
fatty acids, and fat-soluble vitamins, including carotenoids and tocopherols (Venketeshwer Rao 
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Table 2: Red raspberry nutritional information  
Serving Size: Amount in 1 ½ cup (184.5g), fresh weight. 
Calories  96  
Protein  2.25 g 
Carbohydrates  22.05 g 
Fat 1.2  g 
Saturated Fat 0.00  g 
Monounsaturated Fat 0.15 g 
Polyunsaturated Fat 0.75  g 
Total Omega-3 Fatty Acid 232.50 mg 
Total Omega-6 Fatty Acid 459.00 mg 
Dietary Fiber 12.00  g 
Vitamin A 60.90 IU 
Vitamin C 48.30 mg 
Vitamin E 1.65 mg 
Vitamin K 14.40 mcg 
Niacin 1.05 mg 
Vitamin B6 0.15 mg 
Folate 38.70 mcg 
Pantothenic Acid 0.60 mg 
Choline 22.65 mg 
Betaine 1.50 mg 
Calcium 46.05  mg 
Iron 1.20 mg 
Magnesium 40.65 mg 
Phosphorus 53.55 mg 
Potassium 279.00 mg 
Sodium 1.80 mg 
Zinc 0.75 mg 
Copper 0.15 mg 
Manganese 1.20 mg 
Selenium 0.30 mcg 
Water 157.50 g 
Provided by USDA SR-21. 
 
Red raspberries have a distinct phytochemical profile characterized primarily by 
ellagitannins and anthocyanins (Figure 5) (Beekwilder et al., 2005). Ellagitannins contribute to 
more than 50% of total antioxidant capacity (Beekwilder et al., 2005). Ellagitannins are 
hydrolyzable tannins making them more stable such as ellagic acid or gallic acid (Venketeshwer 
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Rao & Snyder, 2010). Ellagitannins can be defined as monomers, oligomers, and complex 
polymers and have hexahydroxydiphenoyl (HHDP) esters of carbohydrates and cyclitols 
backbone that can include additional oxidative transformations (Figure 5) (Venketeshwer Rao & 
Snyder, 2010). The main ellagitannins in red raspberries are oligomers, lambertianin C and 
sanguiin H6 which are trimers and tetramers, respectively that contain an ether link between a 
galloyl hydroxyl oxygen and an HHDP group (Beekwilder et al., 2005) (Venketeshwer Rao & 
Snyder, 2010). Ellagitannins are large molecules (Mw > 1000 Da) and contain between 1 and 3 
gram per 100 gram of dry weight of fruit (Beekwilder et al., 2005). Ellagitannins are found in 
few berries such as cloudberry and raspberry with a lesser extent in strawberries (Beekwilder et 
al., 2005). Anthocyanins contribute about 25% are involved in the pigmentation of the fruit 
(Beekwilder et al., 2005). Anthocyanins are glycosylated polyhydroxy or polymethoxy 
derivative of 2-phenylbenzopyrylium that contain two benzoyl rings separated by a heterocyclic 
ring (Figure 6) (Venketeshwer Rao & Snyder, 2010).  The main anthocyanins in red raspberries 
are cyanidin-3-O-sophoroside, cyanidin-3-O-(2G-glucosylrutinoside) and pelargonidin glycosides 
(Beekwilder et al., 2005). The average content of anthocyanins in red raspberries are 200 to 300 
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Figure 5 :Classification of major polyphenols found in red raspberry. 
 
Figure modified from (Somani, Modi, Majumdar, & Sadarani, 2015) 
 
Red raspberries have an oxygen radical absorbance capacity (ORAC) value of 16 to 20 
𝜇mol (Trolox equivalents) per gram of fruit (Beekwilder et al., 2005). The ORAC value varies 
depending on stage of ripeness at harvest and storage conditions (Beekwilder et al., 2005). When 
the fruit transitions from pink to red anthocyanins accumulate, while ellagitannins diminish by 
30% (Beekwilder et al., 2005). When raspberries are snap-frozen in liquid nitrogen the quality 
and quantity of antioxidants are not affected (Beekwilder et al., 2005). However, the positive 
health benefits of dietary antioxidants are only beneficial to the individual depending on 
bioavailability. Antioxidants are absorbed by the gut before circulating in the blood (Beekwilder 
et al., 2005). Due to the size of ellagitannins direct absorption in the gut may be detrimental, thus 
ellagitannins are hydrolyzed into ellagic acid which is quickly converted into urolithin B by 
colon microbes (Beekwilder et al., 2005). Anthocyanin are typically unchanged from their 
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dietary form, thus indicating that anthocyanins are metabolized in the body, and are not 
effectively absorbed by the digestive system (Beekwilder et al., 2005).  
  
Figure 6: Chemical structures of major polyphenols found in red raspberry. 
Ellagitannins 







2.6 Red raspberries and phytochemical compounds 
 Red raspberry health benefits have been documented in several studies. Previous research 
used whole red raspberry and red raspberry fractions in different in vitro and in vivo models for 
various health conditions (Table 3), sorted by publication date. However, limited studies have 
      31 
demonstrated the effect of whole red raspberries on the MetS, inflammation, lipid metabolism 
and endothelial dysfunction in a model of the MetS.  
 
Table 3: Review of red raspberry literature sorted by publication date. 
Author Amount Red 
Raspberry 
Duration Model Results 
(Bartosz 
Fotschki et al., 
2019) 




and plasma glucose 
level 
(Xue, Du, & 
Zhu, 2019) 10 or 15 𝜇g/mL 
Raspberry 










(D. Xiao et al., 
2019) 



















(V. Khan et al., 
2019) 
100 or 200 
mg/kg 
Raspberry 














and concentration of 
PPAR𝛼 
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Table 3: Review of red raspberry literature sorted by publication date. 
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Table 3: Review of red raspberry literature sorted by publication date. 
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(Gao et al., 
2018) 
1, 10 or 100 
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(Istas et al., 
2018) 200 or 400 g 
Red 
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at 2 and 24 hours. 
(H. Zhang et 
al., 2018) 5% 
Red 
Raspberry 10 Weeks 
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Table 3: Review of red raspberry literature sorted by publication date. 





skeletal muscle but 
not AMPK deficient 
mice. AMPK a1 is 
an important 
mediator for 
beneficial effects of 
RR 
(Bibi, Du, & 
Zhu, 2018) 5% 
Red 






activity index score, 
expression of 
inflammatory 
mediators (IL-6 and 
COX2), infiltration 




(L. Zhao et al., 
2018) 5% 
Red 
Raspberry 10 Weeks 












(S. Khan et al., 
2018) 5% 
Red 









infiltration in white 
adipose tissue and 
      35 
Table 3: Review of red raspberry literature sorted by publication date. 
Author Amount Red Raspberry Duration Model Results 
improved insulin 
sensitivity 
(Wu et al., 
2018) 












in serum, improved 







(Zhu et al., 
2018) 5% 
Red 













al., 2018) 2% 
Red 




TG, glucose, heart 
rate, left ventricular 
enlargement and 
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Table 3: Review of red raspberry literature sorted by publication date. 
Author Amount Red Raspberry Duration Model Results 
1 and 
apolipoprotein E 
and down regulated 
lipoprotein lipase in 
heart tissue 
(Bibi, Kang, 
Du, & Zhu, 
2018) 










& Haque, 2017) 
100 or 200 
mg/kg 
Raspberry 



































(Tsai et al., 
2017) 
50, 150, 300 or 
400 𝜇M 
Raspberry 
Ketone 2 Days 
3T3-
Preadipocytes 
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Table 3: Review of red raspberry literature sorted by publication date. 
Author Amount Red Raspberry Duration Model Results 
(G. D. Noratto, 
Chew, & 
Atienza, 2017) 









peroxidase in liver 
and blood. 
(Sousa et al., 
2016) 
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2016) 
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Table 3: Review of red raspberry literature sorted by publication date. 




levels of TNF-𝛼 and 
TG concentrations. 
Fat concentration 
decreased in liver. 
(K. S. Park, 



















(Li et al., 2014) 
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composition of gut 
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Table 3: Review of red raspberry literature sorted by publication date. 
Author Amount Red Raspberry Duration Model Results 
(Jean-Gilles et 
al., 2012) 












Chen et al 
(2011) 














apoptosis in hepatic 
lesion tissues 
(Torres-Urrutia 









(Suh et al., 
2011) 
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Single Dose Starch Assays Inhibit 𝛼-amylase 
and 𝛼 -glucosidase 
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Table 3: Review of red raspberry literature sorted by publication date. 
Author Amount Red Raspberry Duration Model Results 
(Morimoto et 
al., 2005) 0.5, 1, 2 % 
Raspberry 
Ketone 6 Weeks 
Mice induced 




of body weight, 
liver and adipose 
tissue 
(Mullen et al., 
2002) 24 𝜇L 
Raspberry 




2.6.1 Red raspberry effect on inflammation 
In Table 3, numerous studies have demonstrated that red raspberries can attenuate 
inflammation. Inflammatory response and oxidative stress were hindered in NOD-, LRR- and 
pyrin domain-containing protein 3 (NLRP3) inflammasome induced Caco-2 cells exposed to 
raspberry extract (Xue et al., 2019). Raspberry ketones (100 and 200 mg/kg) for 28 days 
protected Wistar rats induced with isoproterenol-cardiotoxicity against oxidative stress and 
inflammation (V. Khan et al., 2019). Red raspberry extract abolished oxidative damage in DNA 
and altered the inflammatory cascade of UVB-induced human epidermal keratinocytes and a 
nude mouse model (P. W. Wang et al., 2019). Similarly, red raspberry extract ( 1, 10, 100 𝜇g/ml) 
reduced pro-inflammatory markers IL-6, NF-𝜅B and MMP-1 production of UVB-induced 
photoaging in normal human dermal fibroblasts (Gao et al., 2018). Neolignans from red 
raspberry (50 𝜇m) protected SH-SY5Y cells against reactive oxygen species generation and 
mitochondrial dysfunction (Le Zhou, Yao, Lu, et al., 2018b). Supplementation of 5% red 
raspberry diet reduced inflammatory mediators IL-1𝛽, IL-6, IL-7, COX2, TNF-𝛼 and suppressed 
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NF-𝜅B signaling in C57 mice induced with chronic colitis with dextran sulfate sodium (Bibi, Du, 
et al., 2018)(Bibi, Kang, Du, & Zhi, 2018).  A 5% red raspberry diet fed to obesity induced wild-
type mice and mice deficient in the catalytic subunit (𝛼1) of AMP-activated protein kinase for 
10-weeks alleviated the inflammatory response (L. Zhao et al., 2018). Raspberry anthocyanin 
(200 mg/kg-1) for 12-weeks elevated superoxide dismutase and glutathione peroxidase and down 
regulated hepatic expression of pro-inflammatory factors TNF-𝛼, IL-6, NF-𝜅B in obesity-
induced C57BL/6J mice (Wu et al., 2018). Supplementation of 5% freeze dried raspberry for 12-
weeks attenuated pro-inflammatory cytokine expression and macrophage infiltration in white 
adipose tissue and attenuated adipocyte hypertrophy in C57BL/6J mice on a high-fat diet (S. 
Khan et al., 2018)  Obese diabetic mice fed a 5.3% red raspberry diet for 8-weeks improved 
antioxidant status and decreased circulating levels IL-6 and enhanced glutathione peroxidase in 
the liver and blood (G. D. Noratto et al., 2017)(G. Noratto et al., 2016). Raspberry ketone for 10-
weeks decreased body weight and food efficiency obesity in C57BL/6J mice fed a high-fat diet 
(Luo et al., 2016). Obesity induced Wistar rats assigned to raspberry seed oil (7%) for 8-weeks 
decreased plasma TNF-𝛼 levels compared to the control group (B Fotschki et al., 2015).  
Similarly, raspberry ketone suppressed adipocyte differentiation, fat accumulation and 
adipogenesis pathway genes in 3T3-L1 pre-adipocyte (K. S. Park, 2015). RAW264.7 
macrophages stimulated with lipopolysaccharide/IFN-𝛾 exposed to red raspberry crude extracts 
reduced expression levels of IL-1𝛽, IL-6 and inhibited NF-𝜅B activation (Li et al., 2014). Male 
Wistar rats administered a daily dose of 0.8 ml red raspberry seed oil for 5-weeks reduced 
oxidative stress (Pieszka et al., 2013). Superoxide dismutase and paraoxonase activity was 
increased in Syrian hamsters receiving an atherogenic diet with supplementation of red raspberry 
juice (equivalent to 218-305 𝜇g/mL-1 and 45-72 𝜇g/mL-1 anthocyanins and ellagitannins, 
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respectively) for 12-weeks (Suh et al., 2011). Red raspberry (3%) for 3-weeks reduced 
endogenous oxidative DNA damage in CD1-Mice (Aiyer et al., 2008). Raspberry ketones (0.5, 1 
and 2%) for 6-weeks decreased body weight and visceral adipose tissues (epididymal, 
retroperitoneal, and mesenteric) in male ICR mice fed a high-fat diet (Morimoto et al., 2005).   
 
2.6.2 Red raspberry effect on lipid metabolism 
 In Table 3, several studies have demonstrated that red raspberries can alter lipid 
metabolism. Raspberry pomace fed to Wistar rats for 8-weeks affected intestinal microbial 
activity, reduced short-chain fatty acid production in the caecum, increased plasma HDL-C 
levels, decreased atherogenic index, and decreased glucose levels (Bartosz Fotschki et al., 2019). 
Frozen red raspberries (125 g or 250 g) reduced 2-hour insulin and glucose, peak insulin and 
glucose in overweight or obese adults with prediabetes and insulin resistance (D. Xiao et al., 
2019). Orally administered raspberry ketones (100 and 200 mg/kg) for 28 days protected rats 
against dyslipidemia, increased expression and concentration of PPAR-𝛼 and raspberry ketones 
demonstrated to have binding affinity with PPAR-𝛼 (V. Khan et al., 2019). Acrylamide induced-
Wistar rats treated with intraperitoneal injection of red raspberry (300mg/kg-1) inhibited liver 
damage by restoring lipid profile and prevented liver toxicity (A.Al-Salmi, 2019). Hepatocellular 
carcinoma cells induced with red raspberry fruit (25 and 50 mg/ml) and raspberry ketone (200 
𝜇g/ml) inhibited hepatic cell proliferation by regulating PTEN/AKT signaling pathway (H. 
Zhang et al., 2018). Hepatocytes treated with plasma collected from Wistar rats that were fed a 
combination of a high-fat diet and raspberry polyphenolic extract regulated obesity-related 
signals in hepatocytes (Bartosz Fotschki et al., 2018).  C57BL/6J mice assigned to a single daily 
dose of raspberry anthocyanin (200 mg/kg-1) for 12-weeks reduced serum and hepatic lipid 
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profile (Wu et al., 2018). A 2% red raspberry diet for 12-weeks reduced fasting triglycerides and 
glucose, up-regulation of ApoE and down-regulation of lipoprotein lipase in Zucker Fatty fats 
(Kirakosyan et al., 2018). Raspberry ketone (300-400 𝜇M) reduced PPAR𝛾, fatty acid synthase, 
fatty acid-binding protein 4 expression in 3t3-L1 adipocytes (Tsai et al., 2017). Consumption of 
four servings of 10% kcal equivalent of raspberry juice concentrate and raspberry puree 
concentrate per day for 10-weeks decreased hepatic lipid accumulation and altered heme 
oxygenase 1 and hormone sensitive lipase in C57BL/6J mice fed a high-fat diet (Luo et al., 
2017). Wistar rats induced with isoproterenol restored lipid profile by decreasing total 
cholesterol, triglyceride, LDL, VLDL and increasing HDL with 100 and 200 mg/kg of raspberry 
ketones for 28 days (V. Khan et al., 2017). Red Raspberry seed oil (7%) assigned to Wistar rats 
on a high-fat diet for 8-weeks attenuated plasma alanine and aspartate transaminase activities, 
triglyceride concentrations and decreased hepatic fat accumulation (B Fotschki et al., 2015). 
Atherogenic diet-induced gold Syrian hamsters consuming raspberry juice (equivalent to 218-
305 𝜇g/mL-1 and 45-72 𝜇g/mL-1 anthocyanins and ellagitannins, respectively) for 12-weeks 
lowered plasma triglyceride, total cholesterol, and LDL-C levels and increased HDL-C (Suh et 
al., 2011). Using a starch assay, red raspberry extract inhibited 𝛼-amylase and 𝛼-glucosidase 
(McDougall et al., 2005). Hepatic triacylglycerol content was attenuated and norepinephrine-
induced lipolysis was increased with raspberry ketones (0.5, 1 and %) for 6-weeks of obesity-
induced ICR mice (Morimoto et al., 2005).  
 
 2.6.3 Red raspberry effect on endothelial dysfunction 
In Table 3, many studies have demonstrated that red raspberries can restore vascular 
function. Raspberry ketones (100 and 200 mg/kg) for 28-days altered electrocardiogram patterns, 
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infarct size, heart weight to body weight ratio and immunohistochemical assessments of 
isoproterenol-induced Wistar rats (V. Khan et al., 2019). Raspberry consumption (200 and 400 g 
containing 204 or 403 mg of total (poly)phenols, respectively) improved endothelial function 
healthy adult males (Istas et al., 2018). Zucker fatty rats fed a 2% red raspberry for 12-weeks 
resulted in a reduced left ventricular enlargement and wall thickening, altered nicotinamide 
phosphoribosyl transferase expression and upregulation in myocardial adiponectin receptor 1 
(Kirakosyan et al., 2018). Red raspberry phenolic compounds rearranged filamentous actin 
cytoskeleton and decreased phosphorylated-VEGF2 expression of human microvascular 
endothelial cells (Sousa et al., 2016). Lipopolysaccharide-induced RAW264.7 macrophages 
treated with red raspberry crude extracts and anthocyanins demonstrated reduced expression if 
iNOS and COX2 compared to the control group (Li et al., 2014). Blood samples of healthy 
donors were anti-thrombotic when exposed to red raspberry extract (1mg/mL) (Torres-Urrutia et 
al., 2011). Aortic rings exposed to a single dose of raspberry extract increased vasodilation 
response (Mullen et al., 2002).  
In conclusion, a plethora of studies demonstrate the positive relationship between red 
raspberry and health. However, these studies do not investigate the benefits of WRR related to 
the MetS in a valid in vivo model.  
 
2.7 The Obese Zucker Rat a model of the metabolic syndrome  
The obese Zucker rat (OZR) is an ideal model for MetS due to its similar multifactorial 
conditions to that of human MetS and has been cited and used as an experimental model in 
several studies. The OZR has a mutation in the leptin receptor gene (Lepr) (fa/fa). The fa 
mutation was discovered by Lois Zucker in 1961, using a cross between Sherman and Merck 
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stock M rats (Kava, Greenwood, & Johnson, 2017). Leptin is produced by the adipose tissue and 
regulates energy balance (Aleixandre de Artiñano & Miguel Castro, 2009). Leptin production 
correlates with the amount of lipid stored and binds to the leptin receptors of the brain, regulating 
food intake and energy expenditure (Aleixandre de Artiñano & Miguel Castro, 2009). Thus, this 
mutation causes early-onset morbid obesity, mild hypertension, reduced energy expenditure, 
insulin resistance, dyslipidemia, and inflammation (Clément et al., 1998). These characteristics 
of the MetS are present at eight weeks of age (Clément et al., 1998). The OZR is hyperphagic 
compared to their lean littermates as early as 17 days and continues particularly during the 
growth period  during the first 16 weeks of life (Kava et al., 2017). Obesity is present by three 
weeks of age and by 14 weeks the body composition of the OZR is approximately 40% weight 
lipid (Aleixandre de Artiñano & Miguel Castro, 2009). The excessive fat tissue of the OZR is 
associated with abnormal production and over expression of pro-inflammatory mediators 
including IL-1, IL-6, TNF-𝛼, CRP, and monocyte chemotactic protein-1 (Aleixandre de Artiñano 
& Miguel Castro, 2009).  
In addition to obesity, OZR displays elevated plasma levels of triglycerides, plasma 
cholesterol and free fatty acids, and overproduction of hepatic VLDL, which can be observed 
shortly after weaning (Zucker, 1965). The increase in triglyceride concentration in the plasma is 
due to the accumulation of VLDL, and the increase in plasma cholesterol is due to the presence 
of cholesterol in the VLDL and HDL fractions (Aleixandre de Artiñano & Miguel Castro, 2009). 
The excess serum cholesterol in the male obese Zucker rat is transported by HDL as cholesterol 
ester (Lin & Lin, 1985). Adipose tissue activity is correlated with enhanced triglyceride uptake 
via enhanced lipoprotein lipase activity resulting in increased liver lipogenesis and 
hyperinsulinemia (Aleixandre de Artiñano & Miguel Castro, 2009). Whereas, the lipid profile of 
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LZR is similar to that of the Sprague-Dawley and Wistar rats (Aleixandre de Artiñano & Miguel 
Castro, 2009).  
The combination of elevated pro-inflammatory mediators and altered lipid profile are 
major contributors to the development of endothelial dysfunction and increased vascular 
oxidative stress in the OZR (Sista et al., 2019). Endothelium dependent vasodilators are impaired 
whereas constrictors are enhanced in the OZR (Frisbee & Delp, 2006). In the OZR, these 
alterations can reduce blood flow under resting condition or elevate in metabolic demand 
(Frisbee & Delp, 2006). These documented characteristics of the OZR validate the animal as an 
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CHAPTER 3 
3. MATERIALS AND METHODS 
3.1 Animals  
Two sets of animals were used. At 8 weeks of age, 32 obese Zucker rats (OZR) (fa/fa) 
and 32 lean controls (LZR) (Fa/Fa) were purchased from Charles River Laboratories (Raleigh, 
North Caroline). The rats were housed individually in stainless steel mesh-bottom cages in the 
Small Animal Facility at the University of Maine in an environmentally controlled room 
maintained at room temperature and light cycle (12:12 hours light:dark). Body weights were 
measured weekly, to monitor growth and possible weight differences among groups. The 
experimental protocol was approved by the University of Maine Institution Animal Care and Use 
Committee (IACUC: A2017-01-06). Animals were treated in accordance with Guide for the Care 
and Use of Laboratory Animals (8th edition, National Academies Press).  
 
3.2 Diets  
Rats from each animal model (LZR and OZR) were randomly assigned to either a whole 
red raspberry (Rubus idaeus)-enriched diet (WRR), or on a control diet (C), for 8 weeks. A 
standard rodent chow AIN93G was used as the C, while for the test diet 8% w/w WRR powder 
was added substituting for cornstarch (Table 4). Both diets were prepared at Dyets Inc. 
(Bethlehem, PA) and kept at -80℃ in vacuum-packed UV protective bags until use. Freeze-dried 
WRR powder was provided by FutureCeuticals (Momence, IL). The raspberry powder consisted 
of verities: Willamette and Heritage. FutureCeuticals standardized the powder to a total 0.5% 
anthocyanins, 1.5% phenolics and 0.01% ellagic acid. Supplementation of red raspberry powder 
was equivalent to a daily human dose of approximately a cup and a half of fresh red raspberry. 
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Food consumption was measured daily. The WRR powder provided 365 calories/100 g, with 
7.92% protein, 84.42% carbohydrates 0.36% fat, 12.12% fiber, 0.5% total anthocyanins, 1.5% 
total phenolics, and 0.001% ellagic acid. Water and food were provided ad libitum. Food 
consumption was measured daily to monitor possible differences between the groups. 
 
Table 4: Composition of the control and whole red raspberry diet. 
Ingredient AIN-93G (grams/kg) 
AIN-93 +  
8% WRR-enriched 
(grams/kg) 
Casein 200 200 
L-Cystine 3 3 
Sucrose 100 100 
Cornstarch 397.486 317.486 
Whole Red Raspberry 0 80 
Dextrose 132 132 
Soybean Oil 70 70 
t-Butylhdroquinone 0.014 0.014 
Cellulose 50 50 
Mineral Mix 35 35 
Vitamin Mix 10 10 
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3.3 Sample Collection 
At the end of the 8-week experimental period, animals were fasted overnight. Rats were 
anesthetized with CO2 for approximately 2 minutes and exsanguinated by cardiac puncture.  
Set One (Table 5): The thoracic aorta was quickly harvested and placed in a physiological salt 
solution (PSS) (composed of: 118 mM NaCl, 4.7 mM KCl, 25 mM NaHCO3, 1.18 mM KH2PO4, 
1.17 mM MgSO4, 11 mM dextrose, 1.25 mM CaCl), and was cleaned of blood clots and 
connective tissue. The middle segment of the aorta was sectioned into four rings (approximately 
3mm length) and used immediately for the evaluation of vasoconstriction. The remaining end of 
the aorta was sectioned into three pieces (approximately 1mm length) and used for effluent 
measurements. The arch of the aorta was snap-frozen in liquid nitrogen and stored at -80ᵒC until 
further analysis. Blood was collected in a tube containing 200𝜇l of a 5% EDTA solution to 
prevent clotting, centrifuged immediately for 15 minutes at 2300g for plasma separation and 
stored at -80ᵒC until subsequent analysis of inflammatory biomarkers. Liver and adipose tissue 
(AT) were harvested and weighed. Liver samples were fixed in 10% formalin and stored at room 
temperature and stained with Hematoxylin and eosin (H&E) stain for histopathology evaluation 
of basic structures of the tissue. Remaining liver and AT tissues were snap-frozen in liquid 
nitrogen and stored at -80ᵒC for latter mRNA extraction to analyze inflammation.  
Set Two (Table 5): The thoracic aorta was processed in the same way as set one, the four aortic 
rings were immediately evaluated for vasorelaxation. Blood was processed in the same way as 
set one, plasma was analyzed for lipid biomarkers. Liver and adipose tissue (AT) were harvested 
and weighed. Liver samples were fixed in 10% formalin and stored at room temperature and 
stained with Masson’s Trichrome stain for histopathology evaluation of collagen fibers in the 
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tissue. Remaining liver and AT tissues were snap-frozen in liquid nitrogen and stored at -80ᵒC 
for latter mRNA extraction and triglyceride concentration to analyze lipid metabolism. 
 
Table 5: Summary of experiments conducted with two sets of animals. 
Set One (n= 32) 
• Plasma Biomarkers Inflammation 
• Gene Expression in Liver and Adipose Tissue Inflammation 
• Aortic Function  Vasoconstriction 
• Aortic Effluent  Prostanoids 
• Histology of Liver Hematoxylin and eosin 
Set Two (n= 32) 
• Plasma Biomarkers Lipid Profile 
• Gene Expression in Liver and Adipose Tissue Lipid Metabolism 
• Aortic Function Vasorelaxation 
• Histology of Liver Masson’s Trichrome 
 
3.4 Biochemical Assays 
C- Reactive Protein  
Plasma CRP was measured using a CRP Rat ELISA kit (Invitrogen #ERCRP). This test 
is a solid-phase enzyme immunoassay (ELISA) that detects and quantifies the presence of CRP, 
by pairing with a target-specific pre-coated antibody well of a microplate. The enzyme activity 
was measured using an absorbance spectrophotometer Synergy 2 microplate reader (BioTek 
Instruments, Inc.) at 𝜆=450nm and 550nm. 
 
Interleukin-6 
Plasma concentration of IL-6 was measured using Rat IL-6 Quantikine ELISA kit (R&D 
Systems). This test is an enzyme-linked immunosorbent assay (ELISA) detects and quantifies the 
presence of circulating IL-6 by binding to a monoclonal antibody specific coated well of a 
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microplate. The enzyme activity was measured using an absorbance spectrophotometer Synergy 
2 microplate reader (BioTek Instruments, Inc.) at 𝜆=450nm and 570nm 
 
Adiponectin  
Circulating plasma adiponectin was measured using Rat Total Adiponectin Quantikine 
ELISA kit (R&D Systems). This test is a solid-phase enzyme immunoassay (ELISA) that detects 
and quantifies the presence of adiponectin, by binding with a target-specific pre-coated antibody 
well of a microplate reader. The enzyme activity was measured using an absorbance 




Fasted plasma triglycerides were measured using the Triglyceride Colorimetric Assay kit 
(Cayman Chemical #10010303). This enzymatic assay converted triglycerides to glycerol and 
free fatty acids by lipase. The glycerol released was measured using an absorbance 
spectrophotometer Synergy 2 microplate reader (BioTek Instruments, Inc.) at 𝜆=530nm. 
 
Total Cholesterol  
Fasted plasma total cholesterol was measured using the Cholesterol/Cholesteryl Ester 
Assay Kit (abcam #65359).  The enzyme activity was measured using an absorbance 
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High-Density Lipoprotein Cholesterol  
HDL was measured using the HDL and LDL/VLDL quantification Colorimetric kit 
(BioVision. #K613). The enzyme activity was measured using an absorbance spectrophotometer 
Synergy 2 microplate reader (BioTek Instruments, Inc.) at using 𝜆=570nm. 
 
Non- High-Density Lipoprotein Cholesterol  
Plasma non-HDL (VLDL + LDL cholesterol) was calculated by subtracting HDL-
cholesterol from total cholesterol.   
 
Nitric Oxide  
Plasma samples were analyzed for NO concentration using Total Nitric Oxide and 
Nitrate/Nitrite Parameter Kit (R&D Systems, KGE001), following the instructions provided by 
the manufacturer. The colorimetric assay is based on a spectrophotometric detection of a Griess 
Reaction performed at 𝜆=540nm and 690nm on a Synergy 2 microplate reader (BioTek 
Instruments, Inc.).  
 
Prostacyclin I2 
Aortic effluent levels of PGI2 were determined using the competitive ELISA kit 6-keto- 
PGF1α (Cayman Chemicals, #515211). Following manufactures instructions, concentration of the 
secondary metabolite of PGI2 was measured using an absorbance spectrophotometer Synergy 2 
microplate reader (BioTek Instruments, Inc.) at using 𝜆 412nm. Results were normalized to the 
dry weight of the aorta section used. 
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Thromboxane A2 
Aortic effluent levels of TXA2 were determined using the competitive ELISA kit 
Thromboxane B2 (Cayman Chemicals, #501020). Following manufactures instructions, 
concentration of the secondary metabolite of TXA2 was measured using an absorbance 
spectrophotometer Synergy 2 microplate reader (BioTek Instruments, Inc.) at using 𝜆=412nm. 
Results were normalized to the dry weight of the aorta section used. 
 
3.5 Gene Expression 
Messenger RNA from frozen liver, adipose tissue and aorta were isolated, retro-
transcribed to cDNA subjected to two-step, real time, reverse transcription polymerase chain 
reaction (PCR) amplification using rat-specific primer sequences (Qiagen). Relative expression 
of the genes of interest were determined by the ΔΔCt method as described by Livak and 
Schmittgen (Livak & Schmittgen, 2001), relative to housekeeping gene beta-actin (Qiagen) and 
expressed as fold-variation following WRR treatment compared to the control animals.  
 
Messenger RNA extraction from liver 
 From each animal, mRNA was isolated from liver sample using RNeasy Mini Kit 
(Qiagen, #74104). Frozen liver samples (50 mg) were homogenized with buffer (provided with 
the kit) using a TissueRuptor (Qiagen) and centrifuged. Ethanol (96-100%) was added to the 
lysate and added to the column membrane. Following the manufactures protocol from the mini 
kit the RNA was purified with a series of wash steps and eluted with 50𝜇l of RNase-Free water.  
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Messenger RNA extraction from adipose tissue  
 From each animal, mRNA was isolated from adipose tissue sample using RNeasy Lipid 
Tissue Mini Kit (Qiagen, #74804). Frozen adipose tissue samples (100-150 mg) were 
homogenized with buffer (provided with the kit) using a TissueRuptor (Qiagen) and centrifuged. 
Ethanol (96-100%) was added to the lysate and added to the column membrane. Following the 
manufactures protocol from the mini kit the RNA was purified with a series of wash steps and 
eluted with 50𝜇l of RNase-Free water.  
 
Messenger RNA Extraction from aorta 
 From each animal, mRNA was isolated from aorta tissue sample using RNeasy Fibrous 
Tissue Mini Kit (Qiagen, #74704). Frozen aorta samples (10 mg) were homogenized with buffer 
(provided with the kit) using a TissueRuptor (Qiagen) and centrifuged. Ethanol (96-100%) was 
added to the lysate and added to the column membrane. Following the manufactures protocol 
from the mini kit the RNA was purified with a series of wash steps and eluted with 40𝜇l of 
RNase-Free water.  
 
RNA Purity and Concentration 
 The purity and concentration of the purified RNA was measured using a NanoDrop ™ 
Spectrophotometer (ThermoFisher Scientific). The purity the RNA was assessed using 
A260/A280 ratio. RNA that read between 1.8 and 2.1 was considered pure. The ratio of 
A260/A280 and A260/A230 was used to determine the concentration of RNA recovered.  
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Reverse Transcription 
 cDNA was synthesized from mRNA using the RT2 First Strand Kit (Qiagen, #330404). 
Following the manufactures instructions, genomic DNA was eliminated for each RNA sample 
(0.5 𝜇g total) then incubated at 42℃ to initiate reverse transcription. The cDNA was stored at -
20℃ for real-time PCR analysis.  
 
Quantitative PCR Analysis  
 The cDNA product was used as a template for real-time PCR for RT2 Profiler PCR 
Custom Array (Qiagen, #330231) using specific targeted rat specific primer sequences in 
combination with RT2 SYBR Green Master Mix (Qiagen, #330502) and amplified on a 
quantitative PCR system (Bio-Rad CFX96). For each primer (Table 6) and tissue, in duplicates, a 
total of 25𝜇l of the PCR component mix (SYBR green, cDNA, and RNase-Free water) was 
added to each well of the customized 96-well plate. The cycling condition for the PCR system 
was as followed: 1 cycle at 95℃ for 10 minutes for enzyme activation and 40 cycles at 15 
seconds at 95℃, 1 minute at 60℃ for amplification finishing with a melting curve at 65-90℃, 2-
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Table 6: Genes of interest used to evaluate gene expression. 
Gene of Interest Gene Primer Reference ID (Qiagen) Target Tissue(s) 
Inflammation 
C- Reactive Protein Crp RefSeq NM_017096, Rn. 16463 Liver 
Adiponectin Adipoq RefSeq NM_144744, Rn. 24299 Adipose Tissue 
Nuclear Factor-kB NFkb1 RefSeq NM_001276711, Rn. 2411 Liver Adipose Tissue 
Tumor Necrosis 
Factor-Alpha  Tnf RefSeq NM_012675, Rn. 2275 
Liver 
Adipose Tissue 
Interleukin-6 Il6 RefSeq NM_012589, Rn. 9873 Liver Adipose 
Lipid Metabolism 












Pparg RefSeq NM_013124, Rn. 23443 Liver  Adipose Tissue 
ATP Binding Cassette 
Transporter 1 Abca1 RefSeq NM_178095, Rn. 148916 
Liver  
Adipose Tissue 
Lipoprotein Lipase Lpl RefSeq NM_012598, Rn. 3834 Liver  Adipose Tissue 
Acyl-CoA Oxidase 1 Acox1 RefSeq NM_001106508, Rn. 112005 Liver  
Low Density 
Lipoprotein Receptor-
Related Protein 1 
Lrp1 RefSeq NM_001130490, Rn. 22436 Liver 
Acetyl-CoA 
acetyltransferase Acat1 RefSeq NM_017075, Rn. 4054 Liver  
Vascular Function 
Inducible Nitric Oxide Nos2 RefSeq NM_012611, Rn. 10400 Aorta 
Endothelial Nitric 
Oxide Nos3 RefSeq NM_021838, Rn. 44625 Aorta 
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3.6 Hepatic Analysis 
Liver Weight 
Liver tissue was collected, weighed, and flash-frozen in liquid nitrogen within 1-2 
minutes of euthanasia. The percentage of liver weight was calculated by dividing the total body 
weight of the animal at the end of the experimental period by the total liver weight.     
 
Liver Histopathology 
Liver samples were collected and fixed in 10% formalin. Samples were processed on 
Leica TP1020 (Leica, Buffalo Grove, IL) using a 16.5-hour overnight schedule. Tissue Prep2 
(Fisher Scientific) paraffin blocks were prepared and cut at 5𝜇m thickness. Sections were 
mounted on glass slides, deparaffinized and stained following either the hematoxylin and eosin 
(H&E) or Masson’s Trichrome protocol. Samples were examined through a light microscope. 
 
Liver Triglycerides 
Following manufacturer’s instructions, liver homogenates were used to extract and 
quantify triglycerides by the use of Triglyceride Colorimetric Assay Kit (Cayman Chemical 
#10010303). This enzymatic assay converted triglycerides to glycerol and free fatty acids by 
lipase. The glycerol released was measured using an absorbance spectrophotometer microplate 
reader (BioTek) at 𝜆=530nm. 
 
3.7 Endothelial Function  
Vascular studies were conducted on isolated aortic ring preparations to measure Phe-
induced vasoconstriction and Ach-induced vasodilation (Figure 7). The four aortic rings were 
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suspended between two stainless-steel triangles and submerged in 20mL Radnoti tissue baths 
(Radnoti Glass Technology Inc., Monrovia, CA) that contained PSS at 37ᵒC aerated with 95% 
O2/5% CO2 gas mix (pH 7.4). The bottom triangle was fixed to the tissue bath and the top 
triangle was connected to a tissue force analyzer (TFA Model 410; Micro-Med Inc., Louisville 
KY) that recorded the force (g) developed by the aortic ring using DMSI-450 software (version 
1.01: Micro-Med Inc.). 
The isolated rings were pre-loaded with a baseline tension of 1.50 ± 0.01g and pre-
conditioned with a single dose of Ach (10-8 M) and Phe (10-8 M). Each aortic ring was randomly 
assigned to either a treatment that inhibits nitric oxide (NO) synthase with L-N-monomethyl-
arginine (L-NMMA) or a treatment which inhibits cyclooxygenase (COX1 and COX2) with 
mefenamic acid (MFA); or a treatment with no inhibitor. 




The maximum force of contraction (Fmax), the effective concentration at 50% of 
maximum response (EC50), and the vessel sensitivity (pD2, -log10 EC50) were determined (Table 
7). 
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Table 7: Individual dose-response curve. 
Parameters Measured Biological Interpretation Measured by 
Fmax Maximal Force of vessel  
(contraction/relaxation)  
A tissue force analyzer, used 
to calculate % 
increase/decrease of force at 
each Phe/Ach dose 




response curves to semilog 
curves 
pD2 Vessel reactivity  
(receptor-agonist interaction)  
-log EC50 to give normal data 
distribution 
 
Phe-induced vasoconstriction  
Animals from set 1, the four thoracic aortic rings were used to generate a Phe dose-
response curve to evaluate vasoconstriction (Figure 8). The aortic rings were exposed to six 
cumulative Phe doses (from 10-8 to 3 x 10-6 M) and were allowed to reach maximum 
vasoconstriction force for 6 minutes. A single dose of Ach (3 x 10-6 M) was added following the 
last dose of Phe to determine endothelial integrity through the vasorelaxation response. For each 
ring, the maximum force of contraction (Fmax), the effective concentration at 50% of maximum 
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Figure 8: Dose-response curve used to evaluate vasoconstriction. 
 
 
Ach-induced vasodilation  
Animals from set 2, the four thoracic aortic rings were used to generate an Ach dose-
response curve was generated to evaluate vasodilation (Figure 9). Each aortic ring was exposed 
to single dose of Phe (3 x 10-6 M) for 10 minutes which allowed the vessel to reach maximum 
vasoconstriction. Then six cumulative Ach doses (from 10-8 to 3 x 10-6 M) were introduced to 
each of the tissue baths, to allow the aortic rings to reach maximum vasorelaxation for 6 minutes 
after each dose. The maximum relaxation value at each dose of Ach was expressed as a 
percentage from the Phe-induced preconditioned force (0% vasorelaxation). The effective 
concentration at 50% of vasorelaxation response (EC 50) and vessel sensitivity (pD2, -log10 EC 
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The remaining segment of the aorta from each animal was incubated in a 2mL Radnoti 
tissue bath under the same conditions mentioned above (Figure 10). The aorta pieces were 
allowed to equilibrate for 20 minutes before being exposed to a single dose of Phe (10-6 M) for 
10 minutes followed by Ach (10-6 M) for 10 minutes to stimulate prostanoid release. The 
medium was collected and stored at -80ᵒC until further analysis. The aortic tissues were dried at 
room temperature and weighed. Estimated levels of PGI2 (competitive ELISA kit 6-keto- PGF1α 
(6kPGF1α) (Cayman, 515211)) and TXA2 (competitive ELISA kit Thromboxane B2 (TXB2) 
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Figure 10: Method used to evaluate prostanoid concentration using the aortic effluent. 
 
 
3.4 Statistical Analysis 
A two-way analysis of variance (ANOVA) was used to examine the effect of dietary 
treatment (C vs. WRR) and animal model (LZR vs. OZR). The differences between means were 
further analyzed using the Tukey’s Honestly Significant Difference (HSD) test. Results were 
expressed as ± SEM and considered significant at P < 0.05. Statistical analysis was performed 
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CHAPTER 4 
4. RESULTS 
4.1 Animal Weight 
In Figure 11, the average weight of the animals at 8-weeks of age was significantly 
higher in the OZR (394 ±	47g) compared to their litter mates (265 ± 36g). The average weight 
of the animals at 16 weeks of age was significantly higher in the OZR (608 ± 74 g) compared to 
the LZR group (434 ± 68 g). There was no significant difference within each diet group between 
the C and WRR animals.  
 
Figure 11: Average animal weight. 
 
The values are expressed as means ± SEM (n= 8 rats per treatment group) 
a Significant effect of model, LZR-C vs OZR-C (p < 0.05) 
 
4.2 Food Intake  
In Figure 12, average daily food consumption was significantly higher in the OZR (36.3 
± 1.054 g) compared to the LZR group (26.5 ± 0.729 g). Within each diet group (C vs. WRR) 












































a a a a 
a a 
      64 
Figure 12: Average daily food consumption. 
 
The values are expressed as means ± SEM (n= 8 rats per treatment group) 
a Significant effect of model, LZR-C vs OZR-C (p < 0.05) 
 
4.3 Inflammation  
Circulating markers of inflammation in the plasma are reported in Table 8.  
Tumor Necrosis Factor-Alpha  
 Levels of TNF-𝛼 was undetectable in the LZR (Table 8). With the consumption of WRR, 
no changes were observed in plasma TNF-	𝛼 in the OZR. 
 
Interleukin-6 
The levels of IL-6 was higher in the OZR compared to the LZR (Table 8). Following the 
consumption of WRR, IL-6 concentration decreased in the OZR (50.50 ± 3.66 pg/ml vs. 20.69 ± 
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C-Reactive Protein  
 The levels of CRP were higher in the OZR compared to the LZR (Table 8). Plasma 
concentration of CRP decreased in the OZR consuming a WRR-enriched diet from 4250 ± 
1120.12 pg/ml to 1024 ±	108.74 pg/ml (p<0.05). 
 
Adiponectin 
 No significant difference was detected in adiponectin concentrations with animal type or 
diet (Table 8). 
Table 8: Concentration of inflammatory makers in plasma. 
 IL-6 (pg/ml) TNF-𝛼 
(pg/ml) CRP (𝜇g/ml) 
Adiponectin 
(𝜇g/ml) 
LZR-C 8.37 ± 1.07a n.d. 786.80 ± 80.83a 79.24 ± 20.98 
LZR-WRR 15.13 ± 1.53 n.d. 967.50 ± 281.11 66.60 ± 5.72 
OZR-C 50.50 ± 3.66b 25.44 ± 3.92 4250 ± 1120.12b 69.52 ± 4.87 
OZR-WRR  20.69 ± 1.41 27.00	± 4.56 1024 ±	108.74 52.19 ± 5.39 
The values are expressed as means ± SEM (n= 8 rats per treatment group) 
a Significant effect of model, LZR-C vs OZR-C (p < 0.05) 
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Gene Expression of Inflammatory Markers of the Liver  
 Gene expression of inflammatory markers in the liver is represented in Figure 13.  
 
Interleukin-6 
Hepatic gene expression of IL-6 was not significantly different between OZR-C and their 
lean littermates. Following consumption of WRR, expression of IL-6 (Figure 13A), in the OZR 
liver was significantly down-regulated at -45.69% (p<0.05).  
 
Tumor Necrosis Factor-Alpha  
Significant increase in hepatic TNF-𝛼 (Figure 13B) expression was observed in the OZR 
compared to the LZR (p<0.05). Hepatic expression of TNF-𝛼 (Figure 13B) in the OZR liver was 
significantly down-regulated at -13.50% with the consumption of WRR (p<0.05). 
 
Nuclear Factor-𝜅B  
 Hepatic gene expression of NF-𝜅B was not significantly different between OZR-C and 
their lean littermates. Hepatic expression of NF-𝜅B (Figure 13C) in the OZR liver was 
signficantly down-regulated at -20.97% with the consumption of WRR (p<0.05). 
 
C-Reactive Protein  
Hepatic expression of CRP (Figure 13D) was significantly down regulated in the OZR 
compared to the LZR (p<0.05). No significant difference of CRP expression was observed with 
the consumption of WRR in the OZR (Figure 13D). 
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Figure 13 (A-D): Gene expression of inflammatory markers in the liver. 
  
  
Note: A. interleukin-6 (IL-6), B. tumor necrosis factor-alpha (TNF-α), C. 
nuclear factor kappa-light-chain-enhancer of activated B-cells (NF-𝜅B), D. C-
Reactive Protein (CRP) 
 
The values are expressed as means ± SEM (n= 8 rats per treatment group) 
a Significant effect of model, LZR-C vs OZR-C (p < 0.05) 
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Gene Expression of Inflammatory Markers of the Adipose Tissue  
 Gene expression of inflammatory markers in the AT is represented in Figure 14.  
 
Interleukin-6 
Pro-inflammatory molecule IL-6 (Figure 14A) were upregulated in the OZR-C compared 
to the LZR-C (p<0.05). With the consumption of WRR, AT expression of IL-6 (Figure 14A) was 
significantly down-regulated at -49.53% respectively in the OZR compared to OZR-C (p<0.05).  
 
Tumor Necrosis Factor-Alpha  
Pro-inflammatory molecule TNF-𝛼 (Figure 14B) were upregulated in the OZR-C 
compared to the LZR-C (p<0.05). With the consumption of WRR, AT expression of TNF-𝛼 
(Figure 14B) was down-regulated at 18.26%, in the OZR compared to OZR-C (p<0.05). 
 
Nuclear Factor-𝜅B  
 No significant difference was detected in expression of NF-𝜅B in the AT with animal 
type or diet (Figure 14C). 
 
Adiponectin 
 Expression of adiponectin (Figure 14D), an anti-inflammatory molecule, was 
significantly down-regulated in the OZR-C compared to the LZR-C (p<0.05). No significant 
difference of adiponectin expression in the AT was observed with the consumption of WRR in 
the OZR (Figure 14D). 
      69 
Figure 14 (A-D): Gene expression of inflammatory markers in the adipose tissue. 
  
  
Note: A. interleukin-6 (IL-6), B. tumor necrosis factor-alpha (TNF-α), C. nuclear 
factor kappa-light-chain-enhancer of activated B cells (NF-𝜅B), D. adiponectin. 
 
The values are expressed as means ± SEM (n= 8 rats per treatment group) 
a Significant effect of model, LZR-C vs OZR-C (p < 0.05) 
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4.4 Lipid Metabolism  
Circulating Plasma Lipids 
 The concentration of blood lipids is presented in Table 9. 
 
Triglycerides  
 Plasma concentration of TGs was significantly higher in the OZR compared to their lean 
littermates (p<0.05) (Table 9). Following consumption of WRR the concentration of plasma TGs 
increased in the OZR (p<0.05). 
 
Total Plasma Cholesterol 
 Total plasma cholesterol was significantly higher in the OZR compared to the LZR 
(p<0.05) (Table 9). With the consumption of WRR the concentration of plasma total cholesterol 
was attenuated (p<0.05).  
 
High-Density Lipoprotein Cholesterol  
 Plasma concentration of HDL-C was significantly higher in the OZR compared to their 
lean littermates (p<0.05) (Table 9). Following the consumption of WRR the concentration of 
HDL-C was decreased in the OZR.  
 
Non-High-Density Lipoprotein  
 The concentration of non-HDL-C was significantly higher in the OZR compared to the 
LZR (p<0.05) (Table 9). With the consumption of WRR plasma concentration of non-HDL-C 
decreased.  
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Table 9: Plasma concentration of lipids. 
 Triglycerides (mg/dl) 
Total Plasma 
Cholesterol (𝝁g/𝝁l) HDL-C (𝝁g/𝝁l) Non-HDL (𝝁g/𝝁l) 
LZR-C 96.17 ± 12.83a 66.1 ± 5.42a  31.40 ± 2.45a  34.69 ± 3.55a  
LZR-WRR 76.22 ± 4.18 52.44 ± 1.68  30.52 ± 1.49 21.92 ± 1.73 
OZR-C 1227.20 ± 146.14b 221.91 ± 18.34b 111.31 ± 5.61b 110.60 ± 14.69 
OZR-WRR  2149.49 ± 304.70 156.12 ± 6.68 80.36 ± 6.10 75.77 ± 8.76  
The values are expressed as means ± SEM (n= 8 rats per treatment group) 
a Significant effect of model, LZR-C vs OZR-C (p < 0.05) 
b Significant effect of diet, OZR-C vs. OZR-WRR (p < 0.05) 
 
Hepatic Weight 
Total body weight, liver weight and percentage of liver to total body weight was 
significantly higher in the OZR compared to the LZR (p<0.05) (Table 10). With the consumption 
of WRR, liver weight and percentage of liver to total body weight significantly decreased in the 
OZR. 
 
Table 10: Hepatic weight.  
 Body Weight (g) Liver Weight (g) % Liver 
LZR-C 434.30 ± 68a 13.73 ± 0.95a 3.15 ± 0.15a 
LZR-WRR 419.50 ± 50 12.86 ± 0.42 3.10 ± 0.11 
OZR-C 607.60 ± 74 36.58 ± 1.73b 6.10 ± 0.36b 
OZR-WRR 594.20 ± 65 26.12 ± 1.55 4.40 ± 0.27 
The values are expressed as means ± SEM (n= 8 rats per treatment group) 
a Significant effect of model, LZR-C vs OZR-C (p < 0.05) 
b Significant effect of diet, OZR-C vs. OZR-WRR (p < 0.05) 
 
Gross Evaluation  
A single animal representation of livers from OZR-C (Figure 15C) appeared more yellow 
in color and were significantly heavier (Figure 15A) than those of the LZR-C (Figure 15A). With 
WRR consumption, liver weight (Figure 15D) was lower and the yellow color was attenuated in 
the OZR, coming closer in appearance to the liver of their lean littermates (Figure 15A and 15B). 
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In Figure 16 and Figure 17, a single animal representation of livers from the LZR group 
showed normal hepatic architecture (Figure 16A and 16B), whereas livers from the OZR-C 
group (Figure 16C) showed severe accumulation of fat in the hepatocytes. Fat accumulation in 
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Hepatic Concentration of Triglycerides  
 Hepatic concentration of TGs was significantly elevated in the OZR compared to the 
LZR, as reported in Table 11. Supplementation with WRR significantly decreased TG 
accumulation in the liver of the OZR. 
 
Table 11: Hepatic concentration of triglycerides (TG). 
 TG (mg/dl) 
LZR-C 14.14 ± 0.91a 
LZR-WRR 12.81 ± 1.32 
OZR-C 33.45 ± 3.38b 
OZR-WRR 21.41 ± 2.10 
The values are expressed as means ± SEM (n= 8 rats per 
treatment group) 
a Significant effect of model, LZR-C vs OZR-C (p < 0.05) 
b Significant effect of diet, OZR-C vs. OZR-WRR (p < 0.05) 
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Gene Expression of Lipid Metabolism in the Liver 
Gene expression of lipid metabolism in the liver are represented in Figure 18. 
 
Fatty Acid Synthase 
As reported in Figure 2, hepatic gene expression of FAS (Figure 18A) was significantly 
upregulated in the OZR compared to the LZR, independent of diet (p<0.05). With the 
consumption of WRR, hepatic expression of FAS (Figure 18A) was down regulated in the OZR 
p<0.05).  
 
ATP Binding Cassette Transporter 1 
Gene expression of ABCA1 (Figure 18B), was significantly down regulated in the OZR 
compared to the LZR (p<0.05). No significant difference was observed in the OZR with the 
consumption of WRR.  
 
Peroxisome Proliferator-Activated Receptor Gamma 
 Expression of PPAR𝛾 (Figure 18C) was significantly down regulated in the OZR 
compared to the LZR (p<0.05). No significant difference was observed in the OZR with the 
consumption of WRR.  
 
Lipoprotein Lipase  
 The expression of Lpr1 (Figure 18D) was significantly down regulated in the OZR 
compared to the LZR (p<0.05). No significant difference was observed in the OZR with the 
consumption of WRR. 
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Microsomal Triglyceride Transfer Protein 
The expression of Mttp (Figure 18E) was significantly down regulated in the OZR 
compared to the LZR (p<0.05). With the consumption of WRR, hepatic expression Mttp was 
significantly upregulated in the OZR (p<0.05) (Figure 18E). 
 
Acyl-CoA Oxidase 1 
No significant difference was detected in hepatic expression of Acat1 with animal type or 
diet (Figure 18F). Even though hepatic expression of Acox1 (Figure 18F) was not significantly 
different with WRR supplementation in the OZR, a trend toward its increased expression could 
be observed.  
 
Acetyl-CoA acetyltransferase 
No significant difference was detected in hepatic expression of Acat1 with animal type or 
diet (Figure 18G). 
 
Peroxisome Proliferator-Activated Receptor Alpha 
No significant difference was detected in hepatic expression of PPAR𝛼 with animal type 
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Note: A. fatty acid synthase (FAS), B. ATP-binding cassette transporter 
(ABCA1), C. peroxisome proliferator-activated receptor gamma (PPAR𝛾), D. LDL receptor 
protein (Lrp1), E. microsomal triglyceride transfer protein (Mttp), F. Acyl-CoA oxidase 1 
(Acox1), G. Acyl-CoA (Acat1), H. (PPAR𝛼). 
 
The values are expressed as means ± SEM (n= 8 rats per treatment group) 
a Significant effect of model, LZR-C vs OZR-C (p < 0.05) 
b Significant effect of diet, OZR-C vs. OZR-WRR (p < 0.05) 
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Gene Expression of lipid metabolism in the Adipose Tissue  
Gene expression of lipid metabolism in the AT are represented in Figure 19. 
 
Fatty Acid Synthase  
As reported in Figure 19, the AT gene expression of FAS (Figure 19A) was significantly 
down regulated in the OZR compared to the LZR, independent of the diet. Expression of FAS 
was not significantly different with the consumption of WRR in the OZR.  
 
Lipoprotein Lipase  
 Gene expression of LPL (Figure 19B) was significantly down regulated in the OZR 
compared to the LZR. Expression of LPL was not significantly different with the consumption of 
WRR in the OZR. 
 
Peroxisome Proliferator-Activated Receptor Alpha 
 Expression of PPAR𝛼 (Figure 19C) was significantly down regulated in the OZR 
compared to the LZR. Expression of PPAR𝛼 was not significantly different with the 
consumption of WRR in the OZR. 
 
Peroxisome Proliferator-Activated Receptor Gamma 
 Expression of PPAR𝛾 (Figure 19D) was significantly down regulated in the OZR 
compared to the LZR. Expression of PPAR𝛾 was not significantly different with the 
consumption of WRR in the OZR. 
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ATP Binding Cassette Transporter 1 
No significant difference in ABCA1 expression between animal type or diet (Figure 19E). 
 






Note: A. fatty acid synthase (FAS), B. lipoprotein lipase (LPL),	C. peroxisome proliferator-
activated receptor alpha (PPAR𝛼), D. PPAR𝛾, E.  ATP-binding cassette transporter (ABCA1). 
 
The values are expressed as means ± SEM (n= 8 rats per treatment group) 
a Significant effect of model, LZR-C vs OZR-C (p < 0.05) 
b Significant effect of diet, OZR-C vs. OZR-WRR (p < 0.05) 
 
 
4.5 Endothelial Function  
Phenylephrine-induced Vasoconstriction  
The Phe-induced vasoconstriction dose response curve is shown in Figure 20. In the 
absence of inhibitors, the maximal force of contraction induced by Phe was significantly lower in 
the OZR-C (Fmax   0.75 ± 0.05 g) compared with the LZR-C (Fmax 1.15	± 0.05 g, p<0.05) 
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(Figure 20A). Consumption of WRR partially restored Phe-induced vasoconstrictor responses in 
OZR, with a significant increase in the maximal force of contraction (Fmax 0.98 ± 0.03 g 
p<0.05) (Figure 20A). The overall maximal tension of aorta rings with the pre-treatment of NO 
inhibitor, L-NMMA increased (Figure 20B). The Phe-induced vasoconstrictor response 
significantly increased the maximal force of the OZR assigned to a WRR diet compared to OZR-
C (Fmax 2.03 ± 0.12 g and Fmax 1.82 ± 0.14 g, p<0.05 respectively) (Figure 20B). Following 
pre-treatment of rings with MFA, a COX pathway inhibitor, the vasoconstrictor response was 
significantly lower in the OZR-C (Fmax 0.95	± 0.14 g) compared to LZR-C ((Fmax 1.34	± 0.09 
g, p<0.05) (Figure 20C). No significant differences were observed between treatment group in 















Note: A. Phe-induced vasoconstriction response in the absence of the inhibitor. B. Phe-
induced vasoconstriction response with the pre-treatment of L-N-monomethyl-arginine (L-
NMMA). C. Phe-induced vasoconstriction response with the pre-treatment of Mefenamic Acid 
(MFA). 
 
The values are expressed as means ± SEM (n=8 rats per treatment group).  
a Significant effect of animal type, LZR-C vs OZR-C (p < 0.05) 




      82 
Vessel sensitivity (pD2), shown in Table 12, was similar between animal type and was 
unaffected by diet.  Pre-treatment with L-NMMA significantly increased the vessel sensitivity in 
both LZR and OZR (p<0.05). No significant difference was observed either with animal type or 
diet with MFA pre-treatment.   
 
Table 12:Vasoconstriction Vessel Sensitivity (pD2)  
Treatment LZR-C LZR-WRR OZR-C OZR-WRR 
PSS 6.54 ± 0.06a 6.56 ± 0.07a 6.61 ± 0.04a 6.68 ± 0.08 
PSS + L-NMMA 6.81 ± 0.05 6.88 ± 0.06 6.91 ± 0.04 6.89 ± 0.07 
PSS + MFA 6.66 ± 0.06 6.61 ± 0.04 6.79 ± 0.07 6.69 ± 0.06 
Note: No inhibitor (PSS); L-N-monomethyl-arginine (L-NMMA); Mefenamic Acid (MFA).PSS 
(physiological salt solution); L-NMMA (L-N-monomethyl-arginine); MFA (mefenamic acid) 
The values are expressed as means ± SEM (n=8 rats per treatment group).  
a Significant effect between treatment, PSS vs L-NMMA (p < 0.05) 
 
Acetylcholine- induced Vasorelaxation 
The Ach-induced vasorelaxation dose response curve is illustrated in Figure 21. In the 
absence of inhibitors, the OZR-C exhibited exaggerated relaxation response to Ach compared to 
the LZR-C at the first two doses, 10-8 and 3x10-8M (61.64 ± 4.88 % and 92.30 ± 1.98 % vs. 
29.19 ± 3.84 % and 71.40 ± 4.58 %, p<0.05, respectively) (Figure 21A). An attenuated Ach-
induced vasorelaxation response was observed in the OZR-WRR at 10-8 and 3x10-8M (42.12 ± 
5.02 % and 80.69 ± 4.41 %, p<0.05, respectively) compared with OZR-C in the absence of 
inhibitors (Figure 21A). Following pre-treatment with L-NMMA, the maximum relaxation 
response was higher in the OZR-C compared to the LZR-C (80.37 ± 2.95 % vs. 60.65 ± 4.67 %, 
p<0.05, respectively) (Figure 21B). The maximal vasorelaxation response in OZR-WRR (70.99 
±	3.02 %, p<0.05) was lower compared to the OZR-C in the presence of L-NMMA (Figure 
21B). An exaggerated vascular response of the OZR-C was observed compared to the LZR-C at 
      83 
10-8, 3x10-8 and 10-7M (26.09 ± 3.44 %, 56.30 ± 2.03 % and 82.76 ± 1.17 % vs 45.65 ± 6.13 %, 
76.53 ± 4.04 % and 95.90 ± 1.44 %, p<0.05, respectively) following pre-treatment of MFA 
(Figure 21C). Consumption of WRR in the OZR partially attenuated the exaggerated response 
observed in the OZR-C (30.08 ± 3.66 %, 55.58 ± 4.28 % and 82.66 ± 2.78 %, p<0.05, 










Figure 21 (A-C): Acetylcholine (Ach)-induced dose response curve. 
 










Note: A. Phe-induced vasoconstriction response in the absence of the inhibitor. B. Phe-induced 
vasoconstriction response with the pre-treatment of L-N-monomethyl-arginine (L-NMMA). C. Phe-
induced vasoconstriction response with the pre-treatment of Mefenamic Acid (MFA). 
 
The values are expressed as means ± SEM (n=8 rats per treatment group).  
a Significant effect of animal type, LZR-C vs OZR-C (p < 0.05) 
b Significant effect of diet, OZR-C vs OZR-WRR (p < 0.05) 
 
Shown in Table 13, the pD2 of Ach-induced vasorelaxation was higher in the OZR 
compared with LZR, in the absence of the inhibitors (7.63 ± 0.58 vs 7.28 ± 0.04, p<0.05) and 
following L-NMMA treatment (7.09 ± 0.11 vs 6.45 ± 0.16, p<0.05). The pD2 was significantly 
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higher in the absence of the inhibitors compared with the pre-treatment of L-NMMA in all 
groups (p<0.05). Additionally, the OZR assigned to a WRR diet had a significantly lower pD2 
with the pre-treatment of MFA (7.15 ± 0.08, p< 0.05) compared to the treatment with no 
inhibitors.  
 
Table 13: Vasorelaxation Vessel Sensitivity (pD2)  
Treatment LZR-C LZR-WRR OZR-C OZR-WRR 
PSS 7.28 ± 0.04a, b 7.27 ± 0.06b 7.63 ± 0.58b 7.48 ± 0.09b, c 
PSS + L-NMMA 6.45 ± 0.16 6.48 ± 0.10 7.10 ± 0.11 6.90 ± 0.10 
PSS + MFA 7.21 ± 0.10 6.94 ± 0.12 7.39 ± 0.52 7.15 ± 0.08 
Note: No inhibitor (PSS); L-N-monomethyl-arginine (L-NMMA); Mefenamic Acid (MFA); PSS 
(physiological salt solution); L-NMMA (L-N-monomethyl-arginine); MFA (mefenamic acid) 
The values are expressed as means ± SEM (n=8 rats per treatment group).  
a Significant effect of animal type, LZR-C vs OZR-C (p < 0.05) 
b Significant effect between treatment, PSS vs L-NMMA (p < 0.05) 
c Significant effect between treatment, PSS vs MFA (p < 0.05) 
 
Aortic Effluent Prostanoids  
 Aortic effluent prostanoids concentrations are reported in Table 14. In the aortic effluent, 
6kPGF1𝛼 was significantly higher in the OZR compared to the LZR group (p<0.05). The 
concentration of 6ketoPGF1𝛼  significantly decreased in the OZR assigned a WRR diet (p<0.05). 
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Plasma Nitric Oxide  
In Table 14, levels of plasma NO were unaffected among animal type or diet groups.  
 
Table 14: Concentration of aortic effluent.  
 LZR-C LZR-WRR OZR-C OZR-WRR 
6kPGF1𝛼 
(pg/mg of aorta) 5523.36 ± 359.29
a 5789.34 ± 574.32 9644.71 ± 1460.37b 4905.91 ± 550.02 
TXB2  
(pg/mg of aorta) 47.83 ± 5.43 44.84 ± 11.38 61.36 ± 16.15 43.59 ± 12.34 
Plasma NO 
(𝜇mol/L) 9.97 ± 1.01 13.28 ± 1.41 16.61 ± 2.67 15.04 ± 2.31 
Note: 6kPGF1𝛼 (6-keto-prostaglandin F1𝛼); TXB2 (Thromboxane B2); NO (Nitric Oxide) 
The values are expressed as means ± SEM (n=8 rats per treatment group).  
a Significant effect of animal type, LZR-C vs OZR-C (p <0.05) 
b Significant effect of diet, OZR-C vs OZR-WRR (p<0.05)  
 
Gene Expression in the aorta 
In Figure 22A, there was no effect on aortic iNOS expression with animal type or diet 
intervention. The aortic expression of eNOS (Figure 22B) and COX-2 (Figure 22C) was 
upregulated in OZR-C compared with LZR-C (p<0.05). Following consumption of WRR, aortic 
expression of eNOS (Figure 22B) and COX-2 (Figure 22C) were downregulated in the OZR-






























Figure 22 (A-C): Relative gene expression of vascular function in the aorta. 
 
    
 
Note: A. inducible nitric oxide (iNOS), B. endothelial nitric oxide (eNOS) and C. cyclooxygenase-2 
(COX-2).  
 
The values are expressed as means ± SEM (n=8 rats per treatment group).  
a Significant effect of animal type, LZR-C vs OZR-C (p < 0.05) 
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5.1 Red raspberry consumption on inflammation in the obese Zucker rat 
Our results demonstrate that the OZR had significantly higher levels of plasma IL-6 and 
CRP compared to the LZR. Elevated concentrations of IL-6 and CRP have been shown to be 
associated with systemic inflammation. It has been documented that CRP can increase in the 
plasma as much as 1,000-fold after acute inflammatory stimuli (Black, Kushner, & Samols, 
2004). The induction of CRP by the hepatocytes is predominately regulated at the transcriptional 
level by IL-6 (Black et al., 2004). As acute inflammation changes to chronic inflammation, IL-6 
becomes detrimental, favoring the continuous secretion of chemokines, angio-proliferation, and 
anti-apoptotic functions on T-cells (Gabay, 2006). This leads to an increase in serum levels of 
IL-6 and amplifies chronic inflammation (Gabay, 2006). This amplified chronic inflammation 
results in elevated plasma levels of IL-6, CRP and TNF-𝛼 in patients with the MetS (Christiana, 
Casimir, Nicholas, Christian, & Obiefuna, 2016).  
Consumption of WRR in the OZR attenuated the plasma levels of IL-6 and CRP. 
Similarly, 5.3% freeze-dried raspberry consumption attenuated plasma IL-6 levels in obese 
diabetic mice (G. D. Noratto et al., 2017). Male Zucker fatty rats had decreased IL-6 plasma 
levels and no change in CRP levels with consumption of a 2% red raspberry-enriched diet 
compared to the control diet group (Kirakosyan et al., 2018). Male obese Zucker rat consuming a 
wild blueberry diet (8% (w/w)) for 8 weeks had lower CRP and IL-6 levels in the plasma 
compared to the control group (Vendrame, Daugherty, Kristo, Riso, & Klimis-Zacas, 2013). 
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These results suggest that WRR may have effective therapeutic benefit by attenuating the pro-
inflammatory status associated with the MetS. 
In our study, hepatic mRNA level of TNF-𝛼 was significantly up-regulated in the OZR 
compared to the LZR. Liver is a major site of production of inflammatory molecules. Patients 
and animal models with MetS, have an increase of cytokines including IL-6, TNF-𝛼 and NF-𝜅B 
in the liver (Bieghs & Trautwein, 2013). MetS contributes to hepatic inflammation which leads 
to non-alcoholic fatty liver disease (NAFLD) and tissue damage (Bieghs & Trautwein, 2013). 
Previously reported, elevated levels of TNF-𝛼 promote insulin resistance and liver inflammation 
in patients with NAFLD (Adams, Angulo, & Lindor, 2005). It has been documented that hepatic 
expression of 58 out of 222 inflammatory and immune response genes including IL-6 and TNF-
𝛼 was upregulated in morbidly obese patients (Bertola et al., 2010). Nuclear Factor- Kappa B 
activity is responsible for the production of pro-inflammatory cytokines, chemokines and 
adhesion molecules (Tak & Firestein, 2001). The binding of TNF-𝛼 to its receptor initiates a 
cascade of events that leads to the activation of NF-𝜅B, modulating the inflammatory response 
(Bieghs & Trautwein, 2013). Similarly,  IL-6 a pleiotropic cytokine contributes to hepatic 
inflammation (Bieghs & Trautwein, 2013). In the present study, consumption of WRR down-
regulated hepatic expression of IL-6, TNF-𝛼, NF-𝜅B in the OZR compared to OZR-C. In 
alignment with the above results, a high-fat diet supplemented with raspberry anthocyanins 
(200mg/day) for 12 weeks, down-regulated the expression of hepatic IL-6, TNF-𝛼, and NF-𝜅B 
genes (Wu et al., 2018). Hepatic levels of IL-6 and TNF-𝛼 were attenuated with the consumption 
of quercetin in mice (C57BL/6), fed a high-fat diet (Kim, Choi, Joe, Chung, & Yu, 2016). 
Similarly, supplementation of fenugreek seeds (5%(w/w)) for 8 weeks modulated the expression 
of TNF-𝛼 and its receptor in the livers of female obese Zucker rats (Raju & Bird, 2006). 
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Donepudi et al. demonstrated that treatment with  Jamun fruit extract, decreased NF-𝜅B binding 
activity in the liver of C57B1/6 mice that had bile duct ligation (Donepudi, Aleksunes, Driscoll, 
Seeram, & Slitt, 2015). Supplementation of 8% wild blueberries for 8 weeks decreased hepatic 
expression of IL-6 and TNF-𝛼 in male obese Zucker rats (Vendrame, Daugherty, Kristo, Riso, et 
al., 2013).  Thus, red raspberries may modify the mechanisms underlining pro-inflammatory 
mediator production of the liver.   
Up-regulation in expression of pro-inflammatory markers IL-6 and TNF-𝛼 was observed 
in OZR-C compared to the LZR in the AT. As mentioned previously, obesity contributes to the 
MetS, increasing the risk of CVD and T2D. Obesity is characterized by an enlargement and 
increase in adipose tissue size(Ohashi, Shibata, Murohara, & Ouchi, 2014). Excessive fat 
accumulation is associated with increased levels of several inflammatory cytokines (Ohashi et 
al., 2014). Reduction of adipocyte size and number results in a decrease in the synthesis of TNF-
𝛼 and IL-6 and an improvement in the metabolic state (Hotamisligil, 2017). In the present study, 
consumption of WRR downregulated expression of IL-6 and TNF-𝛼 in the AT of the OZR. Kang 
et al. reported that ellagic acid extracted from red raspberry seed flour, reduced expression of IL-
6, IL-8, TNF-𝛼 and monocyte chemoattractant protein 1 (MCP-1) in adipose tissue of C57BL/6 
mice fed a high-fat diet (Kang, Espín, Carr, Tomás-Barberán, & Chung, 2016). Vendrame et al. 
reported down-regulation of IL-6 and TNF-𝛼 in the adipose tissue following consumption of an 
8% wild blueberry in obese Zucker rats (Vendrame, Daugherty, Kristo, Riso, et al., 2013). 
Alternatively, subcutaneous adipose tissue expression of TNF-𝛼 was upregulated in post-obese 
subjects (Jürets et al., 2017).  
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It has been well documented that conditions associated with the MetS increase TNF-𝛼, 
IL-6 and adiposity and decrease adiponectin production resulting in a pro-inflammatory state  
(Aprahamian & Sam, 2011). In alignment, adiponectin gene expression in the AT was down-
regulated in the OZR compared to the LZR in our study. Recent studies have suggested that 
consumption of polyphenols may regulate the low adiponectin levels associated with the MetS 
(Corrêa & Rogero, 2019). Gene expression of adiponectin was up-regulated in epididymal 
adipose tissue of Wistar rats fed a fructose-rich diet with chokeberry extract (200mg/kg of body 
weight daily) added to the drinking water for 6 weeks (Qin & Anderson, 2012). Alternatively, in 
the present study no change in adiponectin expression levels in the AT was observed following 
treatment of WRR in the OZR. Similar observations were reported in cultured human adipocytes 
treated with quercetin, epigallocatechin gallate, and resveratrol at 10 and 25𝜇M for 24 hours and 
10 and 25𝜇M for 48 hours (Derdemezis et al., 2011). Even though pro-inflammatory markers IL-
6 and TNF-𝛼 were down-regulated in OZR-WRR group, no change in body weight between 
OZR-C and OZR-WRR were observed. This may explain why adiponectin expression levels in 
the AT and circulating plasma levels were unaffected following consumption of WRR. Reported 
previously, adiponectin plasma levels of individuals with MetS were unaffected with daily 
consumption (4 cups/day) of green tea (Basu et al., 2011). Similarly, no differences were 
observed in serum levels of adiponectin between the treatment group (30mg cocoa polyphenols, 
80mg soy isoflavones, and 2g myo-inositol) and placebo of postmenopausal women diagnosed 
with MetS after 6 months of intervention (D’Anna et al., 2014). It has been documented that 
reduced adiponectin mRNA levels in adipose tissue were reversed after weight loss in obese 
subjects (Bruun et al., 2015)(W. Yang et al., 2001). Thus, further investigation is needed of the 
dietary role red raspberries in modulating adiponectin levels.  
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In conclusion, this is the first study to demonstrate that 8 weeks of WRR-enriched diet 
attenuates inflammation in the plasma, liver and AT of the OZR (Figure 23). The OZR exhibited 
elevated levels of circulating inflammatory molecules IL-6 and CRP compared to the LZR. With 
the consumption of WRR, circulating levels of IL-6 and CRP were attenuated in the OZR. 
Additionally, WRR down-regulated expression of IL-6, TNF-𝛼, and NF-𝜅B in the liver and IL-6 
and TNF-𝛼 in the AT.  
 
Figure 23: Red raspberry consumption on inflammation in the obese Zucker rat. 
 
 
Key: NF-𝜅B (Nuclear Factor Kappa); TNF-𝛼 (Tumor Necrosis Factor-Alpha); IL-6 
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5.2 Red raspberry consumption on lipid metabolism in the obese Zucker rat 
(VandenAkker, Vendrame, Tsakiroglou, McGilvrey, & Klimis-Zacas, 2020) 
 
The present study demonstrates that WRR enriched-diet positively modulates lipid 
metabolism by reducing circulating plasma total cholesterol and HDL-C levels, attenuating 
hepatic TG accumulation and facilitating its egress from the liver, by up-regulating hepatic 
expression of Mttp and down-regulating Fas. 
In our study, plasma concentration of cholesterol was higher in the OZR compared to 
their lean littermates. Dyslipidemia is a characteristic of the MetS, and hypercholesterolemia in 
particular increases the risk of NAFLD (Du et al., 2016). In this study, a reduction in total 
plasma cholesterol levels was observed in OZR assigned to a WRR diet. Similar results were 
found in Zucker fatty rats supplemented with red raspberry (Kirakosyan et al., 2018) and wild 
blueberries (Vendrame, Daugherty, Kristo, & Klimis-Zacas, 2013). This data suggests that WRR 
have a cholesterol-lowering effect.  
As stated in the introduction, plasma cholesterol is mainly carried in the HDL fraction 
and TG is mainly carried in the VLDL fraction in the male OZR (Aleixandre de Artiñano & 
Miguel Castro, 2009). Both plasma levels of HDL-C and non-HDL-C were significantly higher 
in the OZR compared to their lean littermates, independent of diet. Previous investigations, 
reported that the OZR exhibited an increase in VLDL-TG and HDL-C compared to their lean 
littermates (Schonfeld, Felski, & Howald, 1974). Also, the obese mouse model ob/ob, which has 
a nonsense mutation in the leptin gene similar to that of the OZR, has an increase in plasma 
HDL-C level (Nishina & Wang, 1994). Supplementation of WRR, significantly decreased HDL-
C plasma levels in the OZR with a similar trend seen in non-HDL level. Similarly, an 8% (w/w) 
wild blueberry diet for 8 weeks reduced plasma HDL-C levels in the OZR (Vendrame, 
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Daugherty, Kristo, & Klimis-Zacas, 2013) . We propose that WRR may improve HDL-C 
fraction by positively affecting its clearance (Fisher, Feig, Hewing, Hazen, & Smith, 2012).  
In this study, consumption of WRR alleviated hepatic TG accumulation while elevating 
plasma TG levels in the OZR indicating enhanced mobilization of liver TGs. In parallel with 
these findings the size and weight of the liver was considerably reduced, along with a change in 
appearance bringing it closer to that of the LZR.  This suggests that WRRs may be 
hepatoprotective and may aid in VLDL egress from the liver. Our results are similar to those 
observed in OZRs assigned to fenugreek seed (Raju & Bird, 2006), walnut oil (Fink et al., 2014), 
conjugated linoleic acid (Nagao, Inoue, Wang, Shirouchi, & Yanagita, 2005) and Opuntia ficus 
indica (Nopal) (Morán-Ramos S, Avila-Nava A, Tovar AR, Pedraza-Chaverri J, López-Romero 
P, 2012) enriched diets. A possible explanation of the reduction of TG accumulation in the liver 
with the WRR diet may be related to an enhanced export of TGs from the liver, consequently 
increasing levels of TG in the blood system, as other authors have also observed (Younossi, 
Loomba, Rinella, Bugianesi, & Marchesini, 2017). Although higher levels of TGs are normally 
considered unfavorable to health, in this study we documented a reduction in liver weight and 
hepatic TG accumulation via a decrease in de novo lipid synthesis suggesting that over a long-
term treatment of WRR, a reduction of TG in the plasma may be achieved and this increase may 
indeed be transient. Since this study tested was an eight-week feeding period, it is not 
unreasonable to speculate that a longer dietary intervention may achieve a decrease in plasma TG 
as well.  It has been documented that 12-week consumption of red raspberry powder (2%), red 
raspberry seed flour (equivalent to 0.03% of ellagic acid), or red raspberry anthocyanin 
(200mg/kg-1) supplementation reduced total plasma TG levels in Zucker fatty rats and high-fat 
diet C57BL/6 mice (Kang et al., 2016; Kirakosyan et al., 2018; Wu et al., 2018). 
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Fatty acid synthase is responsible for de novo synthesis of fatty acids (Cohen, Nahari, 
Cerem, Neufeld, & Levi, 1996). In this study, Fas was significantly up-regulated in the liver and 
down-regulated in the AT of OZR compared to the LZR. In some pathological conditions such as 
obesity, Fas gene expression is dysregulated. It has been documented that obese patients have an 
increase in Fas gene expression in the liver (Wakil & Abu-Elheiga, 2009) whereas, Fas gene 
expression is decreased in AT (Diraison, Dusserre, Vidal, Sothier, & Beylot, 2002). Following 
consumption of WRR, the hepatic expression of Fas was significantly down regulated in the 
OZR, while no differences were observed in the AT. Previous studies have reported inhibition of 
Fas expression in HepG2 cells with treatment of mulberry water extract (Ou et al., 2011) and 
cyanidin-3-O-𝛽-glucoside (Guo et al., 2012). Additionally, wild blueberry supplementation 
attenuated hepatic expression of Fas in the OZR (Vendrame, Daugherty, Kristo, & Klimis-Zacas, 
2013). No alterations were observed in expression of Fas in white AT of high-fat induced 
C57BL/6J mice receiving whole table grape powder (5%w/w) for 16 weeks (Collins et al., 
2016). Our observations suggest that WRR may decrease the synthesis of fatty acids therefore 
decreasing hepatic steatosis.    
Microsomal triglyceride transfer protein is critical for proper folding of ApoB. The 
transport of TG from hepatocytes occurs through the assembly of VLDL by the endoplasmic 
reticulum in a two-step process (Schreuder, Verwer, van Nieuwkerk, & Mulder, 2008). The first 
step is the lipidation of apolipoprotein B (ApoB) which creates a pre-VLDL particle and is 
catalyzed by Mttp (Schreuder et al., 2008). The pre-VLDL then becomes enriched with lipids 
and is eventually secreted by the liver. In rodent models and in patients with NAFLD, Mttp 
activity is decreased and accumulation of lipids in the liver is observed (Younossi et al., 2017).  
In this study, Mttp expression was down-regulated in the liver of the OZR compared to the LZR, 
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independent of diet. Similarly, Frink et al. documented that expression of Mttp was down-
regulated in the OZR compared to their lean littermates (Fink et al., 2014). In this study, WRR 
diet, up-regulated hepatic Mttp expression in the OZR, thus enabling ApoB folding and hepatic 
TG export enhanced or aided via ApoB-VLDL. Dietary walnut oil for 10 weeks increased 
hepatic Mttp expression in the OZR (Fink et al., 2014). Similarly, fish oil supplementation for 8 
weeks up regulated Mttp expression in the liver of high-fat diet-induced Sprague-Dawley rats 
(Chiu, Wang, Liu, & Chiang, 2018). Thus, whole red raspberries are able to regulate lipid 
accumulation in the liver through modulation of Mttp expression by increasing the secretion of 
lipid rich VLDL particles.   
Taken together, these results suggest that WRR is able to decrease liver weight, and 
hepatic TG accumulation through down-regulation of hepatic Fas and up regulation of Mttp, 
indicating that WRR modulates hepatic lipid signaling, energy storage and regulation (Figure 
24). 
In conclusion, WRR improved the dyslipidemia, lipid metabolism and hepatic dysfunction in 
the OZR by decreasing lipogenesis through modulation of gene expression in the liver and AT, 
mobilization of hepatic TG from the liver, and decreasing liver weight. We suggest that WRR 
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Figure 24: Red raspberry consumption on lipid metabolism in the obese Zucker rat. 
 
 
Key: HDL-C (High Density Lipoprotein-Cholesterol); Fas (Fatty Acid Synthase Gene); 
Mttp (Microsomal triglyceride transfer protein Gene) 
 
5.3 Red raspberry consumption on endothelial dysfunction in the obese Zucker rat 
(VandenAkker, Vendrame, Tsakiroglou, & Klimis-Zacas, 2020) 
These results demonstrated that 8-weeks of WRR consumption partially normalized the 
vascular function of the OZR aorta by restoring the impaired Phe-induced constrictor response 
and attenuating the exaggerated Ach-induced relaxation response. This is the first study to 
investigate the role of WRR on vascular function.  
It has been previously demonstrated that OZRs develop a dysfunctional vasoconstriction 
and vasorelaxation mechanical response compared to their lean littermates independent of vessel 
type and age (Davidson, Coppey, Kleinschmidt, Oltman, & Yorek, 2009; Lemaster et al., 2017; 
Moral-Sanz et al., 2011; C. L. Oltman, 2006; Christine L. Oltman et al., 2005; Rodriguez-
Rodriguez et al., 2017; Romanko & Stepp, 2005; Vendrame, Kristo, Schuschke, & Klimis-Zacas, 
2014; Vessières et al., 2010). However, endothelial-derived relaxing factors (EDRF) and 
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endothelial-derived constricting factors (EDCF) including NO and prostanoids are inconsistent 
among studies.    
  In this study, the OZR exhibited an attenuated Phe-induced vasoconstrictor response, 
developing a lower maximal force compared to LZR, with no significant difference in vessel 
sensitivity. Studies have also demonstrated inhibition of Phe-induced vasoconstriction response 
in the OZR in the thoracic aorta at 16 weeks of age (Vendrame et al., 2014)(Rodriguez-
Rodriguez et al., 2017), in thoracic, coronary and mesenteric arteries at 16 to 40 weeks of age (C. 
L. Oltman, 2006), and in pulmonary arteries at 17 to 18 weeks of age (Moral-Sanz et al., 2011). 
In our study, the WRR diet partially restored the impaired vasoconstrictor response in the OZR-
C in the absence of inhibitors. With the consumption of WRR the maximal force of contraction 
increased in the OZR with L-NMMA pre-treatment, suggesting their involvement on the NO 
pathway. With pre-treatment of MFA no significant change was observed in the maximal 
vasoconstrictor response of the OZR assigned to a WRR diet. Thus, their involvement on the 
COX pathway may be secondary to the NO pathway.  
With regard to Ach-induced vasorelaxation, the OZR-C exhibited an exaggerated 
relaxation response compared to LZR-C at the first two doses 10-8 and 3x10-8M. Vendrame et al. 
documented similar OZR and LZR responses (Vendrame et al., 2014). A WRR diet decreased 
the maximal relaxation in the OZR. With the inhibition of the NO pathway with L-NMMA, the 
OZR that consumed a WRR-enriched diet exhibited a lower relaxation response, indicating the 
involvement of the NO pathway. An exaggerated vascular function of the OZR-C was observed 
compared to the LZR-C at the first three doses 10-8, 3x10-8 and 10-7M following pre-treatment of 
MFA. With consumption of the WRR diet, vascular function in the OZR at these three doses 
improved but not at 100 percent, suggesting the partial involvement of the COX pathway. 
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Similar results to our study were reported in aortic rings of 16-weeks of age OZR with 
supplementation of wild blueberries (Vendrame et al., 2014). A possible explanation for the 
decreased vasoconstriction response to Phe and the heightened vasorelaxation response in the 
OZR may be due to compensatory mechanisms of the dysfunctional endothelium of the OZR that 
agrees with the proteomic and genomic results of this study.  Ellagic acid, a compound found in 
abundance in red raspberries increased vasorelaxation activity of aorta of 10-12 week old male 
Wistar rat (Yilmaz & Usta, 2013). Moreover, ethyl acetate extract from red raspberries decreased 
blood pressure of spontaneously hypertensive rats at 15 weeks of age (Jia et al., 2011). With the 
consumption of WRR, the OZR partially restored vascular response in the presence and absence 
of the inhibitors suggesting a partial involvement of both the NOS and COX pathways.  
Nitric oxide is a powerful vasodilator synthesized by eNOS which is expressed mainly in 
endothelial cells (Jones et al., 2003), inhibits platelet and leukocyte aggregation and adhesion, 
DNA synthesis, mitogenesis, and proliferation of vascular smooth muscle cells thus promoting 
blood fluidity and preventing thrombosis (Mitchell, Ali, Bailey, Moreno, & Harrington, 2008). 
No changes were observed in plasma levels of NO and expression of iNOS between animal type 
and diet group but gene expression of aorta eNOS, was significantly upregulated in the OZR 
compared to LZR. It has been documented that in conditions of inflammatory and oxidative 
stress of cardiac function, there is an overproduction of NO (Mollace, Muscoli, Masini, & 
Cuzzocrea, 2005). Human umbilical vein endothelial cells exposed to chronic and acute flow 
conditions resulted in elevated eNOS mRNA expression and protein levels (Ranjan, Xiao, & 
Diamond, 1995). It has been proposed that the overexpression of eNOS may enhance blood flow 
by attenuating the vasoconstrictor response during heart failure to increase cardiac output and 
survival (Jones et al., 2003). Following the consumption of WRR, expression of aortic eNOS in 
      100 
the OZR was significantly down-regulated, similar to that of the LZR. This result is in line with 
our observations that WRR consumption improved the vasoconstriction and vasorelaxation 
response in the OZR. Activity of eNOS within the endothelial cells is modulated by several 
factors including reactive oxygen species (ROS) (Sena, Pereira, & Seiça, 2013). Previous studies 
have demonstrated that anthocyanin-enriched extracts of blackberry, black raspberry, blueberry, 
cranberry, red raspberry and strawberry possess free radical scavenging activity due to their anti-
oxidant profiles (Ma et al., 2018). Dihydrobenzofuran-type enantiomeric neolignans isolated 
from red raspberries attenuated ROS generation in SH-SY5Y cells (Le Zhou, Yao, Lu, et al., 
2018a). Additionally, red raspberry leaf extract has been shown to modulate blood platelet 
reactivity and aggregation in ADP-stimulated blood, possibly via the modulation of the redox 
status (Dudzinska, Bednarska, Boncler, Luzak, & Watala, 2016). These studies in addition to our 
data suggest that the antioxidant activity of WRR may modulate factors associated with 
endothelial dysfunction by positively influencing the activity of eNOS from a compensatory to a 
regulatory role.  
Nitric oxide and prostacyclin, a product of the COX pathway, work closely together for 
maintenance of vascular tone (Mitchell et al., 2008). Compromised release of one of these 
molecular entities places results in a dysfunctional endothelium, increasing the risk of 
cardiovascular events (Mitchell et al., 2008). The OZR presented an increase in COX-2 activity 
compared to its lean littermate. Moreover, the expression of COX-2 in the OZR assigned a WRR 
diet was down-regulated. Anthocyanins have been shown to down-regulate expression and 
activity of COX-2 (Karlsson, Nnberg, Fjaeraa, & Wijkander, 2010; Mulabagal, Lang, Dewitt, 
Dalavoy, & Nair, 2009; Seeram, Momin, Nair, & Bourquin, 2001; Seeran, Zhang, & Nair, 2009; 
X. Xiao et al., 2011). In particular, the anthocyanin fraction of red raspberries containing 
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cyanidin-3-sophoroside, cyanidin-glucoside, cyanidin-rutinose and cyanidin-glucosylrutinose 
demonstrated a 47% COX-2 inhibition when tested against a COX-inhibitory assay (Seeram et 
al., 2001). Ellagic acid suppressed COX-2 expression in human monocytes pre-treated with 
lipopolysaccharide (Karlsson et al., 2010). As we expected with the shift to COX-2, the 
concentration of PGI2 was elevated in the OZR-C compared to LZR in the aortic effluent. With 
the consumption of WRR, PGI2 in the aortic effluent was attenuated in the OZR.  
Supplementation of anthocyanin extract from black rice composed of predominately cyanidin-3-
glucoside decreased serum TXA2 and PGI2 ratio in rats fed a high-fat diet (Y. Yang et al., 2011). 
In our study, aortic effluent concentration of TXA2 did not change. Plasma concentration of 
TXA2 was not altered with supplementation of 8% wild blueberries in spontaneously 
hypertensive rats (Kristo et al., 2013). One explanation for these observations is that the COX 
pathway is responsible from the production of prostanoids through COX-1 and COX-2 activity. 
COX-1 is responsible for the production of TXA2, whereas the activation of COX-2 by 
inflammatory stimuli shifts prostanoid synthesis to favor PGI2 and PGE2 (Vichai, 
Suyarnsesthakorn, Pittayakhajonwut, Sriklung, & Kirtikara, 2005)(Nakano et al., 2007). It has 
been documented in numerous studies that COX-2 is upregulated with the MetS and in coronary 
arteries from insulin-resistant obese Zucker rat (Sánchez et al., 2010a) and HUVECs stimulated 
with IL-1𝛽 (Caughey, Cleland, Penglis, Gamble, & James, 2001). It has been proposed that 
MetS up-regulated COX-2 by enhancing the release of relaxant prostaglandins thus playing a 
protective role on endothelial function (Sánchez et al., 2010b). 
These results of upregulation of EDRF’s, eNOS and COX-2 and increase in PGI2 
concentration, mirror our observations on vascular tone of a lessened vasoconstriction and an 
heighten vasorelaxation response of the OZR compared to the LZR, independent of diet. 
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Supplementation of WRR was able to modulate vascular tone in the OZR by down-regulating 
eNOS and COX-2 and decreasing PGI2 concentration in the aortic effluent. We speculate that the 
observed results are due to WRR’s antioxidant and vasodilatory properties; acting as activators 
or inhibitors of multiple signaling pathways of the vasculature, protecting vessels against 
endothelial dysfunction.  
Results from this study suggest that the dysfunctional aorta of the OZR is protected by 
COX-2 production of vasodilator prostaglandins as a compensatory response (Figure 25). In our 
study, the consumption of WRR improved vascular function in the OZR by down-regulating the 
expression of eNOS and COX-2 in the aorta. The decrease in COX-2 activity resulted in a 
decrease in the synthesis of PGI2.This aligns with the mechanistic observations in this study of a 
heightened Phe-induced vasoconstriction response and an attenuated Ach-induced vasorelaxation 
response in the OZR that consumed the WRR diet. 
 
Figure 25: Red raspberry consumption on vascular function in the obese Zucker rat. 
 
 
Key: eNOS (Endothelial Nitric Oxide); NO (Nitric Oxide); COX-2 (Cyclooxygenase-2); 
PGI2 (Prostacyclin I2) 
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In conclusion, this is the first study to demonstrate that 8-week consumption of WRR 
improves the vascular mechanical properties of the impaired vasoconstriction and vasodilation 
function of the OZR and reveals that red raspberries operate through the partial involvement of 
both NO pathway COX pathway. These results combined with previous research document that 
supplementation of diets with WRR may play an important role in improving vascular 
dysfunction, associated with the MetS.  
 
5.4 Significance  
Metabolic Syndrome is a constellation of abnormalities such as insulin resistance, 
hypertension, dyslipidemia, pro-inflammatory, pro-thrombotic, and obesity that are associated 
with an increased risk of CVD and T2DM (Brauna, Bitton-Worms, & le Roith, 2011)(Pothiwala, 
Jain, & Yaturu, 2009). Associated risk factors has been diagnosed in adults and adolescents 
(Engelmann, Lenhartz, & Grulich-Henn, 2004) (Tailor, Peeters, Norat, Vineis, & Romaguera, 
2010). The incidence worldwide have increased over the past two decades, and is estimated to 
rise (Eckel et al., 2010) (Misra & Khurana, 2008). Therefore, this research is imperative to 
increase attention and focus on non-pharmacologic treatments in efforts to reduce the risk factors 
of MetS. There is a great deal of literature documenting strong evidence of dietary changes as a 
treatment for effectively preventing and reversing MetS (de la Iglesia et al., 2016) (Calton, 
James, Pannu, & Soares, 2014). Especially, a diet rich in fruits and vegetables due to their health 
promoting properties (Vendrame, Del Bo’, Ciappellano, Riso, & Klimis-Zacas, 2016) (Cicero & 
Colletti, 2016) (S. Panickar, 2013). However, very little research has demonstrated the activity of 
whole red raspberries on human health.  
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Red raspberries have a unique phytochemical profile which makes this fruit an attractive 
subject to study (Venketeshwer Rao & Snyder, 2010). Currently, there are a limited studies that 
demonstrate the positive benefits of an enriched red raspberries diet in an animal model of the 
MetS. This work is of interest not only to the scientific community but also to health care 
providers and the food industry. By studying the relationship of the consumption of whole red 
raspberries and MetS and its associated risk factors, professionals will be able to manipulate the 
diet to enhance these effects. Whole red raspberries may be able to be promoted as a preventive 
measure for MetS and may also be included and strongly recommended for patients with MetS to 
incorporate whole red raspberries into their diet. These patients may be able to see improvement 
from a diet rich in whole red raspberries without suffering from the harsh side effects and 
financial burden of traditional pharmacotherapies. This research may be able to positively 
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